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ABSTRACT 
Background & Aims: Helicobacter pylori (H. pylori) chronic infection is the major 
cause of peptic ulceration and gastric cancer. Strains with the cag pathogenicity 
island (cagPaI) are more strongly associated with disease. In earlier studies, higher 
levels of interleukin-10 (IL-10) were found in human gastric biopsies with the highest 
H. pylori colonisation density grading. In the current study, experiments were 
performed to determine if this effect could be replicated in vitro using human gastric 
epithelial cell lines. Although IL-10 is abundant in the gastric mucosa, the nature of 
its interaction with the epithelium is unknown. IL-10 receptor (IL-10R) expression on 
gastric epithelial cells was therefore investigated. 
 
Materials & Methods: H. pylori was co-cultured with the human gastric epithelial 
cell lines AGS, MKN28 and MKN45 in the presence or absence of recombinant human 
IL-10 (rIL-10). Bacterial densities were assessed by viable count assays. 
Immunofluorescence microscopy, flow cytometry, RT-PCR and western blotting were 
used to investigate the presence of IL-10R (IL-15Į DQG ,/-5ǃ VXEXQLWV RQ
gastric epithelial cell lines. An IL-10 Fluorokine Kit (R&D Systems) was also used to 
quantify IL-10 binding onto gastric epithelial cells.  
 
Results: Addition of rIL-10 significantly increased the density of H. pylori cagPaI 
positive strains indirectly through effects on gastric epithelial cells. No such 
differences were observed with cagPaI negative strains. AGS cells expressed both 
IL-5Į DQG ,/-5ǃ FRQVWLWXWLYHO\ EXW ,/-5ǃ H[SUHVVLRQ ZDV LQFUHDVHG ZLWK
infection. Conversely, the binding of IL-10 was decreased when AGS cells were 
infected with H. pylori. 
 
Conclusion: This study highlighted a novel finding of constitutive IL-10R expression 
in AGS cells. Interestingly, H. pylori infection of AGS cells downregulated the binding 
of IL-10 to its receptor. The higher level expression of IL-5ǃ IROORZLQJ LQIHFWLRQ
was in opposition to this. Possibly IL-5ǃFRXOGEHVHTXHVWHUHGLQWRRWKHUF\WRNLQH
receptor complexes and therefore is not participate in IL-10 binding. These studies 
have shown that IL-10 has a more complex role in the interaction between H. pylori 
and its host. The IL-10 response now also appears to influence the density of H. 
pylori in the stomach, via cagPaI-dependent effects on epithelial cells. More work 
must be carried out to investigate the mechanisms behind this effect. 
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1.1. Helicobacter pylori background. 
1.1.1. History. 
H. pylori was first discovered by Robin Warren following his three-year observation of 
small curved and s-shaped bacilli in sections from 135 gastric biopsy specimens. During 
that time, this Gram-negative, flagellate (Figure 1) and microaerophilic bacterium was 
regarded as a new species related to the genus Campylobacter due to its similarity in 
morphology and physiology (Marshall & Warren, 1984).  
 
 
 
 
Figure 1. The Helicobacter pylori (Image published in http://commons.wikimedia.org/wiki ). 
 
 
Helicobacters in general are the indigenous biota of the gastro-intestinal tract of virtually 
all mammals from small rodents to dolphins (Blaser, 1998). H. pylori is considered to be 
the human-specific inhabitant of the stomach (Blaser & Atherton, 2004). This bacterium 
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has only been seen in the gastric mucus layer and rarely invades the lamina propria and 
gastric cells (Ko et al., 1999). H. pylori infection is predominantly acquired in childhood 
(Banatvala et al., 1993) and usually persists for the life of the host unless treatment is 
given (Blaser, 1999).  
 
This bacterium is very well adapted to survive in the very harsh acidic and nutrient-poor 
environment of the stomach. It releases the enzyme urease to convert urea from the host 
to ammonia which will raise the gastric pH surrounding its niche (Marshall et al., 1990). 
It also avoids contact with the acidic gastric juice by crossing the thick layer of the mucus 
lining of the stomach using its flagella (Eaton et al., 1992). Once it reaches the host cells, 
it adheres to the gastric epithelial cells using adhesion proteins such as BabA, SabA and 
HpaA (Ilver et al., 1998) and finally secretes factors to initiate inflammation as well as 
damaging the host cells.  
 
The actual route of transmission for H. pylori is unknown but it is more likely to be 
through gastro-oral contact as a higher rate of H. pylori infection was found to be 
associated with history of vomiting in siblings (Luzza et al., 2000).  Although live H. 
pylori has been isolated from human faeces (Thomas et al., 1992), this is rare and the 
faecal-oral route is unlikely to be a common mode of transmission (Malaty et al., 2003). 
It may be significant, however in certain areas which lack good sanitary practices 
(Moreira et al., 2005) and there is also some evidence for this from animal studies (Lee & 
Kim, 2006). Some researchers have also proposed a person-to-person transmission such 
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as from mother to child (Escobar & Kawakami, 2004), through unhygienic food 
preparation or H. pylori-contaminated water (Ahmed et al., 2006).  
Invasive and non-invasive tests have been used to detect the presence of H. pylori in an 
individual. Invasive tests such as bacterial cultures, Campylobacter-like organism (CLO) 
test and histology are based on gastric biopsy samples (Lee et al., 1990). The currently 
used non-invasive tests include rapid 13C-urea breath test (UBT), fecal antigen test and 
serology. The UBT, which is the most commonly used, is thought to be the most reliable 
method of detection with overall accuracy of almost 95% (Kato et al., 2004). This test 
requires the patient to ingest urea with 13C or 14C instead of normal 12C and if present, 
urease enzyme will hydolyse the urea to give out labelled carbon dioxide which will be 
deteced in breath (Bell et al., 1991). The fecal antigen test is normally used to detect H. 
pylori in children and the serology test is usually applied for large case studies. Both of 
these tests are based on enzyme-linked immunosorbent assay (Brown, 2000; Kabir, 
2001). A single non-invasive test may give a false-positive result and therefore should be 
confirmed with another test (Nurgalieva et al., 2006). 
 
The first choice of treatment for H. pylori-infected individuals would be the triple 
therapies composed of a proton pump inhibitor (PPI) and two antibiotics (clarithromycin 
and amoxicillin) (Malfertheiner et al., 2007). Sometimes, a quadruple therapy is 
administered if infection still persists after triple therapy (Veldhuyzen van Zanten et al., 
2000). This is using a combination of a PPI, bismuth substrate and two different 
antibiotics. 
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1.1.2. Epidemiology. 
H. pylori KDVEHHQNQRZQWRLQIHFWKDOIRIWKHZRUOG¶VSRSXODWLRQDVUHYLHZHGE\:LOVRQ
& Crabtree, 2007). In Western countries, such as the USA, the prevalence of H. pylori 
infection was not more than 30% for individuals below the age of thirty years and more 
than 75% of those above the age of 60 years (Graham et al., 1991). There may also be 
differences in prevalence in different parts of the same country (Alpizar-Alpizar et al., 
2005; Palli et al., 2005) and these may be due to differences in socio-economic status, 
since poor and crowded living conditions especially during childhood are associated with 
increased infection rates (Malaty & Graham, 1994). H. pylori prevalence in Western 
countries is now decreasing (Roosendaal et al., 1997) and this is thought to be due to 
improved living standards, good hygiene practice (Rehnberg-Laiho et al., 2001), less 
crowded living condition and the common use of antibiotics in children (Banatvala et al., 
1993). 
 
In Asia, the rate of H. pylori infection is very high but the occurrence of gastric cancer, 
which is associated with the infection, is different between regions. Less developed 
countries such as Thailand and Indonesia are known to have a very high incidence of H. 
pylori infection, but the risk of gastric cancer development is very low in these countries. 
Whereas, countries such as Japan and China have high H. pylori infection rates as well as 
high gastric cancer occurrence (Matsukura et al., 2003). This puzzling scenario, termed 
the Asian enigma (Miwa et al., 2002) was initially thought to be due to the presence of 
less-pathogenic strains in areas with low gastric cancer rates. However, pathogenic H. 
pylori strains were also found in those countries with low gastric cancer rates (Kumar et 
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al., 1998; Singh et al., 2003). Other possible reasons may be variations in the host 
response, polymorphisms in the host genetic reservoir, dietary and other environmental 
factors (as reviewed by Singh & Ghoshal, 2006).  
 
A similar phenomenon, called the African enigma, was also found in Africa where H. 
pylori infection is ubiquitous, but gastric adenocarcinoma was rare in some countries 
(Holcombe, 1992). However, data collected from prospective endoscopic studies in 
African populations has shown that the actual association of H. pylori infection rates and 
disease outcomes is actually similar to those seen in industrialised countries (Agha & 
Graham, 2005). The authors suggested that this could be due to the selected African 
populations being biased towards those who have very limited access to health care and a 
shorter life expectancy. This may be another possible reason for the Asian enigma. 
 
1.1.3. H. pylori-mediated diseases. 
1.1.3.1. Gastroduodenal diseases. 
a) Gastritis. 
During gastric mucosal colonisation, H. pylori adheres to gastric epithelial cells by means 
of adhesion molecules. Bacterial factors such as the CagA protein (Konturek et al., 2000) 
are inserted into host cells which will eventually initiate a pro-inflammatory response. 
Immune cells and lymphocytes are drawn towards the inflamed epithelial cells. This 
chronic gastritis (persistent inflammation of the gastric mucosa) is the initial stage which 
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preceeds the development of peptic ulcers, gastric cancer and MALT lymphoma (Graham 
et al., 2004). 
 
Acute gastritis is rare but has been reported from individuals who deliberately ingested H. 
pylori (Marshall et al., 1985; Sobala et al., 1991). These individuals showed symptoms 
such as fullness, nausea and vomiting. Asymptomatic chronic H. pylori-gastritis is more 
common, but only in a minority of cases will this develop into disease such as peptic 
ulceration. This is depends on the distribution of gastritis and acid level (Figure 2). 
 
 
duodenum
corpus
antrum
Acid 
secretion
Type of 
gastritis
Gastric/duodenal 
histology
Clinical 
condition
Gastric 
metaplasia in 
duodenum
Duodenal 
ulcer
Gastric ulcer 
and gastric 
cancer
 
Figure 2. Gastritis pattern and disease outcome. 
H. pylori-chronic infections in humans generally cause asymptomatic chronic gastritis. However, bacterial 
colonisation in the antrum contributes to antral-predominant gastritis which results in high acid production. 
This leads to gastric metaplasia in the duodenum thus duodenal ulcer. Colonisation in the corpus 
predisposes to pangastritis (or corpus-predominant gastritis) which results in low acid production and 
eventually the occurance of gastric ulcer or gastric cancer (Adapted from Kusters et al., 2006). 
 
 15 
b) Peptic ulcers (duodenal and gastric ulcers). 
Approximately 90% of duodenal ulcers and 70% of gastric ulcers are attributable to 
infection by H. pylori (as reviewed by Ernst & Gold, 2000). A study performed in a large 
series of patients in Italy has confirmed that H. pylori infection is associated with 
duodenal ulcer (Zambon et al., 2005). 
 
The pattern of H. pylori-gastritis and the level of acid load are very important to 
determine the site of ulcer. H. pylori normally colonises the gastric antrum because the 
corpus has a higher number of acid-secreting parietal cells and thus a high production of 
acid (as reviewed by Kusters et al., 2006). Antral-predominant gastritis suppresses D 
cells from producing somatostatin and induces G cells to secrete gastrin (Zavros et al., 
2003). Gastrin is a gastric hormone which induces gastric acid secretion. Somatostatin 
suppresses gastrin production. Hypergastrinaemia stimulates high production of acid 
from parietal cells in the corpus. Over time, high acid levels will be delivered into the 
duodenum and damage its epithelial cells. Gastric metaplasia (replacement of the 
duodenal epithelial cells with those of a gastric type) occurs and the duodenum can then 
be colonised by H. pylori causing inflammation and eventually duodenal ulcer (DU) 
(Robinson & Atherton, 2009). Thus, DU is associated with an antral-dominant gastritis 
(Tham et al., 2001). 
 
For some reason, acid secretion may be impaired in some individuals and H. pylori may 
colonise the corpus leading to corpus-predominant gastritis or pan-gastritis. This type of 
gastritis leads to hypochlorhydria, and hypergastrinaemia occurs, which in turn leads to 
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increased prevalence of atrophy and intestinal metaplasia (El-Omar et al., 1997). 
Hypochlorhydria may be caused by the presence of pro-inflammatory cytokines such as 
IL-ȕ ZKLFK DUH DFLG VXSSUHVVDQW (Beales & Calam, 1998). Atrophy causes the loss of 
acid-secreting parietal cells and further reduces the acid level. Hypergastrinaemia was 
found to correlate with production of COX-2, (Konturek et al., 2000), expression of anti-
apoptotic proteins (Hartwich et al., 2001) and also induction of epithelial cells 
proliferation (Wang et al., 2000). Thus, the combination of the increased rate of cell 
proliferation with less apoptosis in the presence of DNA-damaging compounds, increases 
mutation levels and eventually the risk for carcinogenesis (as reviewed by Fox & Wang, 
2007). 
 
c) Gastric adenocarcinoma. 
In 2007, 13% of all deaths in that year were attributable to cancer with stomach cancer is 
the second most frequent cause of cancer-associated death as reported by the World 
Health Organization (WHO) (http://www.who.int/). Gastric cancer has an extremely poor 
prognosis, the 5-year survival rate is less than 20% (Cenitagoya et al., 1998). H. pylori 
was classified as a group 1 human carcinogen by the International Agency for Research 
on Cancer (IARC) (1994). Since H. pylori infection is known to be the first stage in 
gastric carcinogenesis, studies related to H. pylori pathogenesis are very important.  
 
Strong evidence supports the hypothesis that H. pylori infection is closely-linked to the 
occurrence of gastric cancer. A study showed that only those infected with H. pylori had 
gastric cancer cancer but not uninfected individuals (Uemura et al., 2001). The long-term 
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effect of H. pylori gastritis on the gastric mucosa is also a significant risk factor for 
development of atrophic gastritis and intestinal metaplasia (Kuipers et al., 1995) which 
are the precursors of gastric cancer formation. This was further supported by the fact that 
antibiotic eradication of H. pylori before the appearance of pre-malignant pathology, 
could prevent carcinogenesis (Wong et al., 2004). 
 
&RUUHD¶V PRGHO RI LQWHVWLnal type gastric carcinogenesis suggested that the initial stage 
towards gastric cancer is changing of the gastric mucosal morphology from normal to 
superficial gastritis and this is where H. pylori infection intervenes. This then lead to 
gastric atrophy (loss of glands), which resulted in intestinal metaplasia, followed by 
dysplasia and eventually gastric cancer (Correa, 1992). However, H. pylori infection 
alone is not sufficient to cause gastric carcinogenesis. Other factors such as excessive salt 
intake and smoking may play a role. 
 
d) Gastric mucosa-associated lymphoid tissue (MALT) lymphoma. 
Lymphoma, as the name indicates, is a form of cancer that affects immune cells, the 
lymphocytes, and can be categorised as Hodgkin lymphoma or non-Hodgkin lymphomas 
(http://www.lymphomation.org/aboutNHL.htm). Non-Hodgkin lymphomas can be 
further divided into B-cells, T-cells and Natural Killer (NK) cells neoplasms. The WHO 
KDV UHQDPHG ORZ JUDGH JDVWULF % FHOO O\PSKRPD DV ³([WUDQRGDO PDUJLQDO ]RQH % FHOO
lymphomas of mucosa-associated lymphoid tissue but the short term MALT lymphoma 
was retained. Low grade gastric MALT lymphomas could be transformed to high grade 
which have a lower prognosis than low grade (Chan et al., 1990). 
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The normal gastric mucosa has no lymphoid tissue but the vigorous immune and 
inflammatory response to chronic H. pylori infection could induces lymphoid follicle 
formation (Stolte & Eidt, 1989). This may eventually lead to the development of gastric 
MALT lymphoma (Eidt et al., 1994). Furthermore, H. pylori infection also promotes 
expansion of the transformed cells, as shown in an in vitro study where heat killed H. 
pylori increased the growth of lymphoma cells (D'Elios et al., 1999). It has been found 
that complete reduction of the lymphoma can be achieved by H. pylori eradication alone 
in many cases, provided that the lymphoma has not spread beyond the stomach 
(Montalban et al., 2001). 
 
e) Others. 
Vitamin B-12 (cobalamin) deficiency has been suggested to be connected with H. pylori 
infection. Cobalamin malabsorption is affected by low acid level in the stomach (Andres 
et al., 2004) and H. pylori-associated gastritis can initiate the change of acid level. A 
study on a group of Finnish elderly males showed that in vitamin B-12 deficiency cases, 
75% had caused by H. pylori-induced atrophic gastritis (Sipponen et al., 2003). Kaptan et 
al. have detected H. pylori in 56% of patients with vitamin B-12 deficiency and 
eradication of the bacterium has corrected vitamin B-12 level in 40% of those infected 
(Kaptan et al., 2000). 
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1.1.3.2. Extragastric diseases. 
H. pylori has also been linked to extragastric diseases including idiopathic 
thrombocytopenic purpura, ischemic heart disease, hepatobiliary diseases and iron-
deficiency anaemia. 
 
H. pylori may initiate autoimmune diseases such as idiopathic thrombocytopenic purpura 
(ITP) through the production of autoreactive antibodies via B-1 cell activation 
(Yamanishi et al., 2006). ITP is a haematological condition where there is destruction of 
platelets through auto-immune mediation (as reviewed by Franceschi & Gasbarrini, 
2007). It has been reported that the levels of these autoantibodies decreased after H. 
pylori eradication (Kohda et al., 2002) and elimination of H. pylori from ITP patients is 
effective (Satake et al., 2007). In some cases, ITP may not be directly induced by H. 
pylori infection but by an antibody produced by MALT lymphoma B cells (Noda et al., 
2004). 
 
Iron-deficiency anaemia (IDA) is another haematological condition that has a connection 
with H. pylori infection. This is thought to be due to bleeding ulcers (Gisbert et al., 2007) 
but H. pylori-associated IDA was not reported to have gastrointestinal bleeding (Sarker et 
al., 2008). Thus, the most likely reason for this connection would be that iron absorption 
is disturbed by reduced levels of gastric acid and ascorbic acid (Annibale et al., 2003) 
which is needed in iron uptake. H. pylori eradication has helped to cure this condition 
without the need to continue oral iron treatment in 10 out of 14 H. pylori-positive patients 
(Hershko et al., 2007). The elimination of this bacterium has been proved to enhance the 
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efficacy of ferrous succinate therapy in IDA patients with chronic gastritis (Chen & Luo, 
2007). 
 
Mendall et al. were first to suggest that there was a connection between H. pylori and 
atherosclerotic diseases (Mendall et al., 1994) and this was supported by a study showing 
that patients with ischaemic heart disease had a higher prevalence of CagA positive strain 
infections (Pasceri et al., 1998). Little evidence of this association was found in other 
studies (Stone et al., 2001) but a few serological studies have reported that there is an 
association between H. pylori infections, especially cagA-positive strains, with the risk of 
coronary heart disease in middle aged white men (Gunn et al., 2000; Singh et al., 2002). 
The link with atherosclerosis remains controversial although it has been reported that H. 
pylori can cause damage to the walls of blood vessels and cause inflammation (Kowalski 
et al, 2001). H. pylori infection is also reported to be one of the risk factors for the 
development of cardiovascular diseases (CVD) among Korean adults (Sung et al., 2005). 
This was supported by association of antibodies against H. pylori-heat shock protein 60 
(H. pylori-HSP60) and CVD risk factors (Okada et al., 2007). 
 
A link between Helicobacter infection and hepatitis C-associated cirrhosis has been 
reported (Rocha et al., 2005). H. pylori DNA has been found in liver samples from 
patients with hepatitis C virus-positive cirrhosis with and without hepatocellular 
carcinoma. Helicobacter DNA was found in 8 out of 20 liver samples from patients with 
primary liver carcinoma (Huang et al., 2004).  
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1.1.4. Determinants of H. pylori disease outcome. 
H. pylori infections do not always result in the development of disease and the vast 
majority (85-90%) of infected people remain asymptomatic. Who develops disease 
depends on several factors including the virulence of the infecting H. pylori strain, the 
genetic susceptibility of the host, environmental co-factors such as smoking, diet and 
concurrent infections (Atherton, 1997). 
 
1.1.4.1. Major H. pylori virulence factors. 
a) Cytotoxin-associated gene (cag) pathogenicity island (cagPaI).  
The cagPaI is a region of DNA made up of about 30 genes which encode a type IV 
secretion system (T4SS). Infection with H. pylori strains possessing the cagPaI are 
approximately twice as likely to lead to peptic ulceration and gastric adenocarcinoma. 
CagA, a protein encoded by this island, is injected into the epithelial cytosol through the 
T4SS (Fischer et al., 2001) and is used as a marker for the presence of the PaI 
(Akopyants et al., 1998). Delivery of CagA is also triggered by interactions between 
CagL, a specialized adhesin encoded on cag3D, ZLWK LQWHJULQ Į5ȕ1 receptor on gastric 
epithelial cells (Kwok et al., 2007).  
 
The T4SS itself has been found to induce expression of pro-inflammatory cytokines when 
interacting with host cells (Segal et al., 1999) by a mechanism which does not involve 
CagA but H. pylori cell wall components e.g. peptidoglycan instead. Peptidoglycan is 
recognised by the host defence molecule, NOD1, and this leads to NF-ț% DFWLYDWLRQ
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(Viala et al., 2004) and increased expression of pro-inflammatory genes such as 
interleukin-8 (Holck et al., 2003). Other than CagA and peptidoglycan, this T4SS may 
also translocate other important bacterial factors (Christie & Vogel, 2000) with a role in 
pathogenesis. The importance of the cagPaI was demonstrated when its deletion or 
disruption of several cag genes, blocked H. pylori-mediated induction of the 
proinflammatory chemokine interleukin-8 (IL-8) by gastric epithelial cells in vitro 
(Akopyants et al., 1998). This factor is an important chemoattractant for neutrophils and 
lymphocytes. Neutrophil infiltration in the gastric mucosa was significantly more severe 
in patients who were infected with cagE-positive strain compared to cagE-negative strain 
(Maeda et al., 2002). These conditions show that the presence of the cagPaI makes a big 
contribution towards induction of inflammation. 
 
Upon its injection into epithelial cells via the T4SS, the CagA protein is recognized by 
Src family kinases (Stein et al., 2002) and phosphorylated at the tyrosine residues in 
EPIYA motifs (Asahi et al., 2000).  It is this phosphorylated-CagA which interacts with 
host signalling molecules, e.g. tyrosine phosphatase SHP-2 (Higashi et al., 2002), which 
leads to changes in epithelial cell morphology (Figure 3). CagA proteins from different 
H. pylori isolates vary in their tyrosine phosphorylation motifs (TPMs) (Stein et al., 
2002). An In vitro study reported that H. pylori strains which deliver CagA with more 
TPMs, induced more profound cytoskeletal changes to gastric epithelial cell lines (Argent 
et al., 2004). Strains producing CagA with more TPMs, increase its binding to SHP-2 and 
thus increase the cellular effects. This was reported for Asian strains which were 
associated with increase risk of gastric cancer (Azuma et al., 2002).  
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In addition, many reports show the linked between clinical disease outcome and presence 
of cag. The risk for the development of gastric cancer is higher in infection with a cagA-
positive H. pylori strain in comparison with a cagA-negative strain (Blaser et al., 1995). 
Furthermore, CagA enhances production of reactive oxidative species (ROS) and might 
induce oxidative stress to the gastric mucosa (Farinati et al., 2003). Infection with a 
cagA-positive H. pylori strain is also associated with an increased prevalence and 
intensity of antral atrophy and intestinal metaplasia (Sozzi et al., 1998). 
 
 
 
 
Figure 3. CagA interaction with host molecules and cellular consequences. 
Once transported into host epithelial cells via the T4SS, CagA is phosphorylated and interacts with SHP-2, 
the host signalling molecule. This interaction leads to morphological changes and proliferation of host 
cells. Other than CagA, peptidoglycan is also translocated into host cells and recognised by NOD1. This 
promotes NF-ț%DFWLYDWLRQDQGLQGXFHVLQIODPPDWRU\UHVSRQVHV7DNHQIURP.XVWHUVet al., 2006). 
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b) Vacuolating cytotoxin A (VacA). 
All H. pylori strains possess a vacA gene (Phadnis et al., 1994) and approximately half of 
them secrete an active VacA protein (Leunk et al., 1988). This protein is a toxin which 
induces massive vacuole formation in epithelial cells in vitro and reduces the 
proliferation of T-cells (Smoot et al., 1996). It has been suggested that this inhibition of T 
cell clonal expansion may allow H. pylori to evade the adaptive immune response and 
establish chronic infection (Sundrud et al., 2004). The toxin is capable of forming pores 
in gastric epithelial cells which transport interstitial fluids together with urea towards the 
bacterium (Tombola et al., 2001). In this way, the bacterium gains nutrients as well as 
balancing the pH in its surrounding niche by converting urea to ammonia which 
eventually helps H. pylori to grow. VacA also acts by loosening the tight junctions 
between cells and causes damage to the epithelium (Pelicic et al., 1999). 
 
The vacA gene is polymorphic and may contain s1 or s2, i1 or i2 and m1 or m2 alleles ( 
Figure 4). The i1 type has been closely linked with peptic ulcer disease (Basso et al., 
2008). Type s1/m1 strains produce a higher level of cytotoxin activity in vitro than type 
s1/m2 (Atherton et al., 1995). Several studies have shown that infection by more virulent 
and highly pathogenic s1/m1 strains of H. pylori increase the risk of gastric cancer 
(Enroth et al., 2000). Although s1/m1 strains were associated with the disease, VacA is 
not thought to act via inflammation but due to inducing tissue damage. 
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Type s1/i1/m1 VacA
Type s1/i1/m2 VacA
Type s2/i2/m2 VacA
Type i1
Type i1
Type i2
 
 
Figure 4. Polymorphism in the vacA gene. 
Between strains, the vacA gene in H. pylori varies in the s (signal), i (intermediate) and m (mid) regions. 
The s region encodes the signal peptide (determines cytotoxic activity and level of secretion) and may exist 
as type s1 or s2. The i region is located within the p37 subunit (also determines cytotoxic activity) and may 
exist as type i1 or i2. The m region encodes part of the p58 binding subunit (determines binding to host 
cells) and may exist as type m1 or m2. Type s1/i2/m2 is also exist and has similar activity with type 
s2/i2/m2 (Adapted from Atherton, 2006). 
 
 
c) Duodenal ulcer promoting gene A (dupA). 
This gene is present in the genome sequence of H. pylori strain J99 as two overlapping 
genes but is present as one open reading frame in most other strains (as reviewed by 
Robinson et al., 2007). The dupA gene was found mostly to be connected with the 
presence of peptic ulcers but not gastric cancer. In one study, this gene was significantly 
associated with increased risk of duodenal ulcer but appeared to protect against H. pylori-
induced gastric cancer in patients from South Korea, Japan and Colombia (Lu et al., 
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2005a). Others have shown a significant association of dupA with peptic ulcer diseases in 
an Iraqi population (Hussein et al., 2008) and that dupA positive strains are inversely 
associated with gastric cancer in Iranian patients (Douraghi et al., 2008).  
 
In addition, a study in China recently showed that duodenal ulcer patients had the highest 
prevalence of dupA positive strains compared to gastric cancer and gastric ulcer patients 
(Zhang et al., 2008). However, in Brazil, dupA positive strains are highly prevalent but 
infection with them was not significantly associated with gastric cancer or duodenal 
ulcer, both in adults and children (Gomes et al., 2008). Importantly, Lu et al. showed that 
dupA+ infections are associated with increased levels of IL-8 in the gastric mucosa and a 
more severe neutrophil infiltration (Lu et al., 2005a). This indicates that the high risk of 
disease is driven by induction of inflammation. 
 
d) Outer inflammatory protein (OipA). 
The oipA gene can also induce IL-8 expression from gastric epithelial cells (Yamaoka et 
al., 2000). The presence of OipA is correlated with duodenal ulceration (Yamaoka et al., 
2002) and gastric cancer (Yamaoka et al., 2006). Additional evidence of the importance 
of this gene comes from the fact that an oipA knockout mutant strain of H. pylori failed to 
colonise Mongolian gerbils (Akanuma et al., 2002) and it induced lower levels of gastric 
inflammation in mice than its wild-type parent (Yamaoka et al., 2002). 
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e) Other outer membrane proteins. 
Multiple H. pylori outer membrane proteins can mediate H. pylori adherence to gastric 
epithelial cells. Examples of these proteins are BabA, SabA, HpaA, Omp18, AlpA, AlpB 
and HopZ. BabA (blood group antigen binding adhesion A), one of the most-studied 
adherence factors, binds to Lewis B blood group antigen, which is found on epithelial 
cells (Ilver et al., 1998). It facilitates H. pylori colonization and increased IL-8 responses, 
which in turn increase mucosal inflammation (Rad et al., 2002). SabA (sialic acid-
binding adhesion) expression was increased in strains obtained from patients with gastric 
cancer, intestinal metaplasia gastric atrophy (Yamaoka et al., 2006). Interactions between 
bacterial adhesion and a host receptor can alter disease outcome in an animal without 
affecting colonization levels (Guruge et al., 1998). If certain H. pylori strains adhere 
more strongly to the host cells, then toxins or other effector molecules can be efficiently 
delivered to the cells which may increase the level of damage and inflammation.  
 
f) HP-NAP. 
HP-NAP is another factor that can activate neutrophils. HP-NAP activates mast cells to 
release the contents of granules and the pro-inflammatory cytokine IL-6. These factors 
can then recruit monocytes and neutrophils to the site of infection (Montemurro et al., 
2002). The gene for this H. pylori neutrophilic activating factor is called napA (Evans et 
al., 1995) and is able to induce neutrophils to adhere to endothelial cells (Evans et al., 
1995). It can also mediate the binding of H. pylori to cell surface via interaction with 
carbohydrates (Teneberg et al., 1997). HP-NAP has also been found to induce a strong 
 28 
Th1 response, induces neutrophils to produce reactive oxygen species and thus increase 
inflammation level as well as damaging host cells (Montecucco & de Bernard, 2003). 
 
1.1.4.2. Host genetics. 
Inflammation caused by H. pylori infection is mediated by an array of pro- and anti-
inflammatory cytokines (as reviewed by Lochhead & El-Omar, 2007). Individuals with a 
more pro-inflammatory genotype are at more risk of developing disease as a consequence 
of this infection. Single-nucleotide polymorphisms in several genes encoding pro-
inflammatory cytokines can influence the clinical outcome of the H. pylori infection (as 
reviewed by Algood & Cover, 2006).  
 
A group of researchers have reported that IL-1 gene cluster polymorphisms suspected of 
enhancing production of IL-ȕDUH DVVRFLDWHGZLWK DQ LQFUHDVHG ULVNRI ERWK H. pylori-
induced hypochlorhydria and gastric cancer (El-Omar et al., 2000). These 
polymorphisms were also associated with more severe inflammation and an increased 
prevalence of intestinal metaplasia and atrophic gastritis (Rad et al., 2004). In addition, 
polymorphisms that enhance the expression of TNF-Į are associated with an increased 
risk of gastric cancer development (Machado et al., 2003), and duodenal and gastric 
ulcers (Zambon et al., 2005). IL-8 gene polymorphism has also been reported to play a 
role in the severity of gastric inflammation. The IL-8-251T allele is associated with 
increased production of IL-8 in the H. pylori-infected gastric mucosa (Lee et al., 2005).  
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Polymorphisms in a range of other genes (e.g. IL-17F, IL-7R IFNGR2 and TLR4) are 
also reported to be associated with increased risk of gastric cancer and its precursors (as 
reviewed by Lochhead & El-Omar, 2007). 
 
Polymorphisms in the IL-10 gene are also important in modulating disease outcome. This 
will be discussed in detail in section 1.4.5.1. 
 
1.1.4.3. Environmental factors. 
Other than host genetics and bacterial virulence factors, environmental factors such as 
smoking and diet can also contribute to the development of gastritis, peptic ulceration and 
gastric cancer. 
  
Cigarette smoking has been linked to many diseases including gastric cancer and peptic 
ulcers (as reviewed by Sherman, 1991). A study conducted in Venezuela has reported 
that people who were current smokers or had smoked previously, had significantly 
increased risks of intestinal metaplasia, dysplasia and premalignant pathology (Kato et 
al., 2004). Tobacco smoking has also been associated with a higher risk of gastric cancer 
(You et al., 2000) and risk of duodenal ulceration (Martin et al., 1989) for those infected 
with H. pylori. 
 
Although diet does not play a major role in duodenal disease, greater consumption of 
fresh fruits and vegetables has been shown to protect against risk of gastric cancer. In the 
study of Mayne et al. antioxidants such as vitamin C have been shown to have an inverse 
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association with the risk of noncardia gastric carcinoma (Mayne et al., 2001). A vitamin 
C dietary supplement may also protect from progression of gastric mucosal atrophy 
(Sasazuki et al., 2003). However, a high salt intake and especially high dietary nitrite 
from meat is directly associated with noncardia gastric cancer risk (Mayne et al., 2001). 
Research has also found that excessive intake of sodium chloride augments colonization 
of H. pylori in mice and humans, which would in turn aggravate gastritis (Fox et al., 
1999). Others have observed a dose-dependent increase in gastric cancer risk with the 
consumption of highly salted food such as salted fish roe and salted fish preserves among 
middle-aged Japanese men and women (Tsugane et al., 2004). Furthermore, a high salt 
diet increases the expression of interleukin-ȕ LQ WKH JDVWULF HSLWKHOLDO FHOOV in vitro 
(Zhang et al., 2006). 
 
1.2. Host response. 
H. pylori infection induces vigorous innate and adaptive immune responses but the host is 
still unable to clear the organism from the mucosa. Gastric epithelial cells, the first-line of 
defense during H. pylori infection, express a number of innate pattern recognition 
receptors (PRRs) such as TLR2, 4, 5 and 9 (as reviewed by Lee & Josenhans, 2005) 
which recognise bacterial components such as flagellin and lipopolysaccharide (LPS). 
NOD1, an intracellular pattern recognition molecule that specifically responds to 
peptidoglycan products, is activated by cell wall component of H. pylori which enters 
gastric epithelial cells when the cag T4SS penetrates the cells (Viala et al., 2004). TLR2 
could also respond to peptidoglycan but not from H. pylori (Travassos et al., 2004). 
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Activation of PRRs on gastric epithelial cells leads to expression of pro-inflammatory 
factors such as interleukin-8 (IL-8) (Holck et al., 2003). Many of these molecules act as a 
chemotactic factor for neutrophils and lymphocytes, which also respond to H. pylori by 
producing further pro-inflammatory factors such as IFN-ȖDQGDQWLbacterial effectors such 
as defensin. 
  
1.2.1. The gastric mucosal barrier.  
Gastric mucosa is protected by a thick layer of mucus comprised mostly of epithelial 
mucins MUC5AC and MUC6 (Taylor et al., 1998). H. pylori swims through this and can 
interact with other mucins e.g. MUC1, which is expressed on the surface of the gastric 
epithelium cells (Linden et al., 2004). H. pylori infection can alter the expression levels 
of some mucin genes. In a study by Wang and Fang, gastric cancer patients with H. 
pylori infection had lower expression of MUC1, MUC5AC and MUC6 but higher MUC2 
expression (Wang & Fang, 2006). MUC2 is normally expressed in intestinal (Carrato et 
al., 1994) but its present in the gastric mucosa is a marker for intestinal metaplasia (Babu 
et al., 2006). 
 
MUC1 is a large, heavily glycosylated mucin expressed on the apical surface of a variety 
of epithelia including the mammary gland, gastrointestinal, respiratory, urinary and 
reproductive tract (as reviewed by Gendler, 2001). Recently, the epithelial mucin MUC1 
has been demonstrated to limit the level of H. pylori colonization in the mouse gastric 
mucosa (McGuckin et al., 2007) by acting as a releasable decoy (Linden et al., 2004). 
The binding of H. pylori to MUC1 depends on the size of the MUC1 variable number of 
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tandem repeats (VNTR) domain as well as bacterial pathogenicity. It was found that 
larger VNTR regions and infection with a more pathogenic strain increased adhesion 
(Costa et al., 2008). The most likely reason for this is that larger VNTR regions may 
provide more sites for H. pylori adhesion factors to bind.  
 
The MUC1 extracellular domain is highly polymorphic (Gendler et al., 1990) and the 
presence of different alleles of this membrane glycoprotein affects susceptibility to 
gastritis. It was found that the shorter the alleles of MUC1, the more risk of acquiring 
gastritis (Vinall et al., 2002) and gastric cancer (Carvalho et al., 1997) for that specific 
individual. What is more, mice deficient in MUC1 had 5-fold higher H. pylori 
colonisation densities and developed atrophic gastritis (McGuckin et al., 2007). 
 
Another important molecule that is expressed on gastric epithelial cells during H. pylori 
infection is B7-H1 (programmed death-1 ligand) (Das et al., 2006). The B7 family 
provides signal that is very important for stimulating and inhibiting T cell activation (as 
reviewed by Coyle & Gutierrez-Ramos, 2001). When the gastric epithelial cells are 
infected with H. pylori, naive T cells can develop into regulatory T-cells with a 
CD4+CD25+FoxP3+ phenotype and this depends upon expression of B7-H1 (Beswick et 
al., 2007). Up-regulating the expression of this molecule may help H. pylori to inhibit T 
cell responses in an indirect way. 
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1.2.1.1. Gastric cytokines and inflammatory cell infiltrates. 
Cells of the gastric epithelial layer, the first line of defense during H. pylori infection, 
secrete cytokines and chemokines which stimulate the migration of granulocytes, 
monocytes and lymphocytes into the inflamed mucosa (as reviewed by Robinson et al., 
2007). Increased expression of the chemokine receptor CCR4 on antral CD4+ T cells 
from infected compared to uninfected stomach mucosa tissue has been found (Lundgren 
et al., 2005b) which guides homing of these cells to the stomach. In all H. pylori-infected 
subjects, levels of IL-8, IL-ȕ ,/-6, IFN-Ȗ and TNF-Į DUH LQFUHDVHG LQ WKH JDVWULF
mucosa compared to uninfected healthy individuals (Lindholm et al., 1998). Some of 
these factors may be secreted by epithelial cells, but the source of many factors is the 
infiltrating immune and inflammatory cells. These cells release cytokines in response to 
encountering bacteria or bacterial components in the lamina propria. 
 
IL-8 is one of the important factors that drive the influx of neutrophil towards the 
infected cells and the amount of IL-8 expressed by gastric epithelial cells in response to 
H. pylori is sufficient to induce neutrophil chemotaxis (Yamada et al., 2001). Both in 
vivo and in vitro studies have shown increased levels of IL-8 in association with H. pylori 
infection (Kim et al., 2001; Ren et al., 2001; Seo et al., 2004; Robinson et al., 2008). 
Higher serum IL-8 has also been seen in gastric cancer patients than in controls without 
gastric cancer or H. pylori-infected controls (Konturek et al., 2003). The induction of IL-
8 expression is thought to be mediated through NF-ț% DQG DFWLYDWRU SURWHLQ-1 (AP-1) 
(Chu et al., 2003).  
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Neutrophils are generally the most abundant cells that populate the infected gastric 
epithelial cells. However, H. pylori evades the killing and phagocytosis activity by 
neutrophils. H. pylori strains, especially cagPaI-positive strains, could induce neutrophils 
to produce reactive oxygen species (ROS) and therefore cause tissue damage (as 
reviewed by Allen, 2001). Other than being phagocytes, neutrophils also produce 
inflammatory cytokines in response to H. pylori infection, such as IL-8, IL-ȕDQG71)-Į
(Alvarez-Arellano et al., 2007). A study demonstrated that, wild type and neutrophil-
depleted mice have similar intensities of gastric inflammation indicating that neutrophils 
may play a minor role in the response to H. pylori infection (Ismail et al., 2003).  
 
Macrophages are another set of immune cells that mediate phagocytosis but H. pylori 
also avoids killing by these cells. However, it was found that the type II strains, which are 
cagPaI-negative, could be rapidly engulfed and killed by macrophages compared to 
cagPaI-positive type I strains. The type I strains were found residing in megasomes, a 
combination of phagosomes of cultured macrophages (Allen et al., 2000). H. pylori has 
been reported to invade the lamina propria and be captured by macrophages (Ito et al., 
2008). Another possible strategy of H. pylori to persistently colonise its host is by 
inducing arginase from macrophages (Gobert et al., 2002) to counter the activity of 
inducible nitric oxidase (iNOS) also by macrophages (Fu et al., 1999). 
 
Dendritic cells (DCs) are potent connectors between the innate and adaptive immune 
responses because they can capture, process and present the antigen especially to T-cells 
(as reviewed by Banchereau et al., 2000). It was found that immature DC from either H. 
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pylori-positive or H. pylori-negative human donors could be activated by H. pylori 
(Kranzer et al., 2004) for example by inducing IL-12 production by these cells (Guiney et 
al., 2003). It is still unclear how H. pylori actually interacts with DCs, but both H. pylori 
and DCs were found to manipulate epithelial tight junctions. It has been suggested that 
DCs could open up tight junctions in the gastric epithelium and project dendrites between 
cells to sample bacteria from the lumenal surface (Rescigno et al., 2001). 
 
1.2.1.2. Reactive oxygen and nitrogen species. 
In chronic H. pylori infection, there is usually a persistent gastric neutrophilia and this is 
thought to be particularly important in pathogenesis through release of damaging 
inflammatory mediators such as reactive oxygen species (ROS) (as reviewed by 
Robinson et al., 2007). H. pylori-induced chronic gastritis is the initial step towards 
carcinogenesis, since prolonged exposure of the tissue to ROS causes DNA damage and 
leads to mutation (Farinati et al.71)ĮDQG ,/-8 are considered to be the main 
oxidative stress markers that trigger increased levels of ROS (Augusto et al., 2007). Xu et 
al. identified one source of oxygen radicals in human gastric epithelial cells to be 
hydrogen peroxide (H2O2). This is specifically produced via H. pylori-induced spermine 
oxidase activity and resulted in apoptosis and DNA damage (Xu et al., 2004). Superoxide 
(O2-) is another major source of intracellular ROS (as reviewed by Imlay, 2003). When 
various H. pylori strains were used to infect primary cultures of human gastric mucosal 
cells, the CagA protein was found to play an important role in the induction of oxidative 
stress and DNA damage (Bagchi et al., 2002). This was confirmed in vivo where gastric 
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biopsies from patients infected with cagA-positive H. pylori had higher scores for 
gastritis and greater oxidative DNA damage overall (Farinati et al., 2003).  
 
In addition, nitric oxide (NO) generated by the enzyme inducible nitric oxide synthase 
(iNOS) during inflammation may also injure gastric epithelial cells. NO has antimicrobial 
activity and can inhibit growth of viruses, parasites and Gram-positive organisms by 
causing DNA damage (as reviewed by Jaiswal et al., 2001). However, too much exposure 
to NO is lethal for cells and continued release of NO by the tumour cells is reported to 
promote tumour growth (Jenkins et al., 1995). NO plays several roles in cancer 
development: an endogenous mutagen; an angiogenesis factor; an enhancer of 
protooncogene expression and an inhibitor of apoptosis (as reviewed by Jaiswal et al., 
2001). iNOS expression in H. pylori-stimulated gastric epithelial cells is thought to be 
regulated by NF-ț%DFWLYDWLRQ/LPet al., 2001). 
 
1.2.1.3. Cyclooxygenase-2 (COX-2). 
Cyclooxygenase (COX) is a rate limiting enzyme in the synthesis of prostaglandins and 
exists initially in two isoforms, COX-1 and COX-2 (as reviewed by Konturek et al., 
2005). A third isoform of this enzyme, COX-3 has also been characterized. COX 
enzymes may be inhibited selectively or non-selectively by non-steroidal anti-
inflammatory drugs (NSAIDs) (Chandrasekharan et al., 2002). Prostaglandins have 
diverse functions including maintaining mucosal integrity and blood flow (Takeuchi et 
al., 1999). They also induce inflammation, fever and pain. Prostaglandins are also 
reported to be tumourogenic (Plummer et al., 1995) and mutagenic (Boolbol et al., 1996).  
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COX-2 is well known for its role in gastrointestinal carcinogenesis, and the growth of 
tumours is markedly attenuated in COX-2 deficient (COX-2-/-) mice but not in COX-1-/- 
or wild type mice (Williams et al., 2000). Chulada et al. found that both COX-1 and 
COX-2 are important in intestinal tumourogenesis (Chulada et al., 2000). COX-2 
inhibition using its specific inhibitors rofecoxib (Konturek et al., 2003) and celecoxib 
(Steinbach et al., 2000), in clinical studies significantly reduced the development of 
colonic cancer.  
 
In connection with H. pylori infection, COX-2 mRNA expression is significantly 
increased in patients with gastritis compared to uninfected patients with and without 
gastritis (Fu et al., 1999; Tatsuguchi et al., 2000). H. pylori infection induces expression 
of mRNA and protein for COX-2 via activation of NF-ț% LQa time-dependent manner 
(Kim et al., 2001). Meyer et al. reported that when peripheral blood mononuclear cells 
(PBMCs) were infected with H. pylori, COX-2 is induced and prostaglandin E2 is 
produced (Meyer et al., 2003). Prostaglandin E2 is reportedly involved in the proliferation 
of human gastric cancer cells (Lim et al., 2002).  
 
 
1.2.2. Innate immunity and inflammation. 
1.2.2.1. Pattern recognition receptors. 
Generally, the initiation of innate immune response to bacterial pathogens begins when 
the host recognizes the pathogens through its pathogen-associated molecular patterns 
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(PAMPs) such as LPS, flagellins and DNA. The host uses pattern recognition receptors 
(PRRs) to recognize PAMPs. In the case of H. pylori infection, NOD1, the host PRR, is 
activated by H. pylori peptidoglycan which enters gastric epithelial cells when the cag 
T4SS penetrates the cells (Viala et al., 2004). NOD1 is encoded by the caspase-
recruitment domain 4 gene (CARD4) (Strober et al., 2006). Interaction of peptidoglycan 
with NOD1 leads to activation of NF-ț%)LJXUHZKLFKLVWKHNH\WUDQVFULSWLRQIDFWRU
controlling expression of pro-inflammatory cytokines genes, including IL-8 (Chu et al., 
2003; Fox & Wang, 2007). The T4SS transports CagA into host cells and induces host 
cell signalling which leads to NF-ț%DFWLYDWLRQ1)-ț%ZDValso found to be activated by 
cagE-positive strains (Maeda et al., 2002), further supporting the presence of cag which 
is essential to initiate inflammation.  
 
The other well-known PRRs are the Toll-like receptors (TLRs), a family of 11 proteins 
expressed on cell surfaces. TLRs are involved in the development of many pathological 
conditions including responses to infectious diseases, tissue damage, autoimmune & 
neurodegenerative diseases and cancer (as reviewed by Chen et al., 2007). TLRs 
recognize a wide range of molecules and some of them recognize Gram-negative bacteria 
including TLR2 (recognizes lipoprotein and peptidoglycan), TLR4 (recognizes Gram-
negative LPS), TLR5 (recognizes flagellin) and TLR9 (recognizes bacterial CpG DNA 
motifs) (as reviewed by Algood & Cover, 2006). It has been suggested that TLR2 maybe 
the dominant innate immune receptor for recognition of gastrointestinal Helicobacter 
species (Mandell et al., 2004).  
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Figure 5. The induction of pro-inflammatory responses by H. pylori.  
When (i) peptidoglycan (PGN) or (ii) the CagA protein are delivered into infected gastric epithelial cells 
via a functional T4SS, they will be recognized by host molecules. (i) PGN recognition by NOD1 leads to 
NF-ț%DFWLYDWLRQ7KLVDFWLYDWLRQLVYLDWKHLQWHUDFWLRQVRI12'ZLWKUHFHSWRU-interacting serine-threonine 
kinase (RICK). The NF-ț%FRPSOH[HVDUHWUDQVORFDWHGLQWRWKHQXFOHXVDQGHYHQWXDOO\H[SUHVVLRQRI,/-8, 
CXC-chePRNLQHOLJDQG&;&/DQGWKHDQWLPLFURELDOSHSWLGHKXPDQȕ-defensin-2 (hBD-2) will be up-
regulated. (ii) Phosphorylated CagA protein triggers a signalling cascade that also leads to activation of 
NF-ț%DVZHOODVDFWLYDWRUSURWHLQ-1 (AP-1) and eventually IL-8 expression by host cells (Adapted from 
Fox & Wang, 2007). 
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There is evidence that H. pylori-derived LPS is an important virulence factor for 
induction of gastritis. H. pylori infection increases levels of TLR4 located in both the 
cytoplasm and at the apical surface of the epithelial cells (as reviewed by Chen et al., 
2007). However, TLR4 stimulation by H. pylori is weak and this helps H. pylori to evade 
the immune response (as reviewed by Lee & Josenhans, 2005). H. pylori infection of 
epithelial cells also induces NF-ț%FHOOXODUUHVSRQVHVYLD7/5DQG7/5in vitro (Smith 
et al., 2003) and NF-ț% activation is important for the induction of the inflammatory 
response. 
 
1.2.2.2. Antibacterial peptides. 
Antibacterial peptides are compounds used by the host immune system to attack invading 
pathogens. Their major killing mechanism is by disrupting microbial membranes. These 
compounds can also exhibit extracellular effects including inhibition of DNA, RNA or 
protein synthesis as well as activating antimicrobial enzymes that degrade components of 
the microbe (Kindt et al., 2007). Defensins and cathelicidins are among the peptides 
isolated from diverse sources in the body. 
 
,WKDVEHHQVKRZQWKDWKXPDQȕ-defensin 2 (hBD-2) can be induced by H. pylori infection 
of the MKN45 cell line, and this was restricted to strains containing the cagPaI (Wada et 
al., 1999). Activation of NF-ț%LVHVVHQWLDOIRUWKHLQGXFWLRQRIWKHK%'-2 gene (Wada et 
al., 2001), which has been detected in gastric cancers from patients with H. pylori 
infection (Uehara et al.  2Q WKH RWKHU KDQG KXPDQ ȕ-defensin 1 (hBD-1) is 
constitutively expressed by gastric epithelial cells in vitro and in vivo, and not up-
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regulated by H. pylori infection (O'Neil et al., 2000). It has been reported that hBD-2 but 
not hBD-3 expression is NOD1-dependent (Boughan et al., 2006). 
 
Besides defensins, cathelicidins have also been found in relation to H. pylori infection. 
This is another group of antimicrobial peptide found in mammals (as reviewed by 
Gennaro & Zanetti, 2000). It has been reported that the production of LL-37/human 
cationic antimicrobial peptide 18 (hCAP18), the single known cathelicidin in man, is up-
regulated in the epithelium and gastric secretion of H. pylori-infected patients (Hase et 
al., 2003). This human cathelicidin has also been found elsewhere in the human body 
such as the lung (Bals et al., 1998), in sweat (Murakami et al., 2002b) and in the oral 
cavity (Murakami et al., 2002a). 
 
1.2.3. Adaptive immune responses. 
1.2.3.1. Humoral responses. 
H. pylori infection induces strong antibody responses in the human gastric mucosa, both 
in asymptomatic carriers and duodenal ulcer patients. In a study, higher frequencies of 
both IgA- and IgM-secreting cells are found in infected subjects compared to noninfected 
subjects but there was no difference in numbers of IgG-secreting cells (Mattsson et al., 
1998). This could be due to the difference in endothelial expression of adhesion 
molecules directing trafficking of B cells to the inflamed gastric mucosa. In addition, the 
presence of serum antibodies specific for H. pylori antigen was also reported and has 
been utilised in a diagnostic test (Kindermann et al., 2001). 
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However, production of antibodies may damage the gastric inflammatory response and 
hinder elimination of the bacteria (Akhiani et al., 2004). It was reported that IgA together 
with IL-10 helps H. pylori to evade host resistance against infection (Akhiani et al., 
2005). Furthermore, antibodies are unnecessary for protection, since vaccination is 
possible in B-cell deficient mice (Sutton et al., 2000).  
 
1.2.3.2. T-cell responses. 
The prominent type of T-cells during the immune response to H. pylori is the CD4+ 
T-cell but CD8+ are also present in the gastric mucosa. H. pylori virulence factors are 
able to alter the T-cell response. For example, VacA may reduce T-cell proliferation 
(Smoot et al., 1996) and impair the priming of immune responses by disrupting antigen 
presentation (Molinari et al., 1998). Nevertheless, VacA can indirectly induce IL-12 
secretion which is needed for T- cell expansion (Gebert et al., 2003). H. pylori has 
mechanisms for evading cellular immunity. Some H. pylori strains that are capable of 
binding to Lewis antigens can interact with DCs and eventually block the development of 
T helper (Th) 1 cells (Bergman et al., 2004). H. pylori infection has caused the 
up-regulation of B7-H1 expression by gastric epithelial cells which can suppress T-cell 
activity when engaged (Das et al., 2006). The role of different T-cell subsets (Table 1) 
which are important in H. pylori-mediated disease is discussed below. 
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 Th1 Th2 Th17 Treg 
Inflammation 
and 
pathology 
More severe 
'¶(OLRVet 
al., 1997) 
Less severe 
(Smythies et 
al., 2000) 
Increased 
neutrophil 
infiltration 
(Shiomi et al., 
2008) 
Suppressed 
(Lundgren et 
al., 2005a) 
High levels 
and disease 
outcome 
Peptic ulcers 
(Robinson et 
al., 2008)  
Lack of peptic 
ulcers 
(Fox et al., 
2000) 
Peptic ulcers 
and gastric 
cancer 
(Mizuno et 
al., 2005) 
Cancer 
progression 
(Enarsson et 
al., 2006) 
Successful 
vaccination 
Required 
(Taylor et al., 
2008) 
Not required 
(Akhiani et 
al., 2002) 
Required 
(DeLyria et 
al., 2009) 
Inhibits 
efficacy in 
mice 
(Watanabe et 
al., 2002) 
Colonization Reduced in 
mice and 
humans 
(Holck et al., 
2003) 
Increased in 
mice (Fox et 
al., 2000) 
Reduced in 
mice (Shiomi 
et al., 2008) 
Increased in 
mice 
(Raghavan et 
al., 2003) and 
humans 
(Robinson et 
al., 2008) 
Table 1. T-helper subsets in connection with H. pylori infection (Adapted from Robinson & Atherton, 
2009). 
 
 
 
a) CD4+ T-helper cell response. 
Many studies have reported the importance of CD4+ T-cells in the response to H. pylori 
infection. They are present in the gastric antral infiltrates of H. pylori-infected patients 
with duodenal ulcers (D'Elios et al., 1997). An increased number of CD4+ T cells have 
been found in the gastric antrum but not in the duodenum of H. pylori-positive 
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individuals (Lundgren et al., 2005b). CD4+ T-cells can be further divided into subsets of 
T helper (Th) 1, Th2, Th17 and regulatory T-cells. 
 
Th1 
The importance of Th1 cells in modulating H. pylori-mediated disease was shown when 
there was no induction of gastritis in mice deficient in this subset of T-cells after H. 
pylori infection (Eaton et al., 2001). This was supported by the finding that H. pylori-
LQIHFWHG ,)1Ȗ GHILFLHQW PLFH LQGXFH OHVV LQIODPPDWLRQ DQG GR QRW GHYHORS JDVWULWLV
(Akhiani et al., 2002). In additLRQ&',)1ȖDUHWKHPRVWSUHYDOHQWVXEVHW of CD4+ T 
cells during H. pylori infection (Bamford et al., 1998). A study in rhesus macaques 
showed an increased prevalence of ,)1ȖCD4+ T cells during acute H. pylori infection 
(Mattapallil et al., 2000).  
 
The presence of some H. pylori-virulence factors may have a role in skewing the 
response towards Th1. Strains that posses the cagPaI and vacA were correlated with the 
induction of IL-12 in samples from patients with H. pylori-gastritis (Takeshima et al., 
2009). oipA gene was also found to promote the expression of Th1-associated cytokines 
(Yamauchi et al., 2008). Furthermore, administration of HP-NAP was found to promote 
Th1 response as well as suppress Th2 response in in vivo allergy model (D'Elios et al., 
2009). 
 
Human response with Th1 polarization showed a more severe disease outcome. Th1 
cytokines (IL-,)1ȖDQG71)ĮEXWQRW7KF\WRNLQH,/-4) were found in samples 
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from antral biopsies of patients with peptic ulcers (D'Elios et al., 1997). Furthermore, 
peptic ulcers as well as a more severe gastritis level were associated with an increase in 
WKHQXPEHURI,)1Ȗ-secreting Th1 cells in the infected human gastric mucosa (Robinson 
et al., 2008). 
 
In addition, the presence of a Th1 response is important for successful H. pylori-
immunization as shown with decrease in number of bacteria colonising the gastric 
mucosa of wild type but not the IL-DQG,)1ȖGHILFLHQWPLFHDIWHUFKDOOHQJHZLWKH. 
pylori (Akhiani et al., 2002; Taylor et al., 2008).  
 
Th2 
In patients with gastritis, a Th1 response was found to predominate but for those with 
gastric cancer and its related pathology, a Th2 response was strongly induced (Ren et al., 
2001). The ability of Th2 or IL-4 deficient mice to be equally protected as wild type mice 
after immunization and challenge implies that a Th2 response is not required for 
successful H. pylori vaccination (Akhiani et al., 2002). However, a Th2 response is 
needed to suppress inflammation as IL-4 deficient mice elicit a more severe gastritis 
compared to wild type animals (Smythies et al., 2000). 
 
Th17 
Th17 is another important subset and was recently added in the studies of H. pylori-
mediated immune responses.  When IL-17 deficient mice were infected with H. pylori, 
the levels of neutrophils as well as bacterial numbers in the gastric mucosa were found to 
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be lower than in wild type mice (Shiomi et al., 2008). Together with a study showing 
high IL-17 concentrations at gastric ulcer sites and correlations with IL-8 expression 
(Mizuno et al., 2005), these suggested that IL-17 may promote neutrophil influx and 
inflammation. This was also supported by a study which found increased IL-17 
expression as well as neutrophil-attracting chemokines in H. pylori-infected mice 
(DeLyria et al., 2009). Recent findings showed that IL-17 neutralising antibody 
administered to immunised and Helicobacter felis-challenged mice prevented the 
clearance of bacteria and reduction of gastric inflammation (Velin et al., 2009).  
 
Regulatory T-cells (Tregs). 
Tregs have suppressive effects on other cells and their association with H. pylori 
infection will be discussed with further detail in section 1.3.4. 
 
b) CD8+ cytotoxic T-cells. 
Together with CD4+ T-cells, CD8+ T-cell responses have also been found in relation to 
H. pylori infection but these have been studied much less intensively. An absence of 
CD4+ T cells in H. pylori-infected mice resulted in increased gastritis and influx of 
CD8+ T cells, indicating that CD4+ T-cells usually suppress the inflammatory response 
to H. pylori (Tan et al., 2008). A study on samples from duodenal ulcer patients and 
asymptomatic H. pylori carriers showed a substantial production of IFN-Ȗ, mainly by 
CD8+ cells (Quiding-Jarbrink et al., 2001). This type of T-cells may also express 
inflammatory cytokines such as IL-17 (Caruso et al., 2008). They are mostly found as 
memory cells in the gastric mucosa of H. pylori-infected individuals (Azem et al., 2006). 
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In peripheral blood of H. pylori-infected duodenal ulcer patient, elevated levels of CD8+ 
T-cells were found (Figueiredo Soares et al., 2007). However, one study contradicted this 
finding where the presence of CD8+ T-cells were correlated with non-ulcer H. pylori 
infection (Goll et al., 2005).  
 
1.3. Regulatory T-cells. 
1.3.1. Background and function. 
 T cells are an important component of the human adaptive immune response to H. pylori 
and among these are the regulatory T cells (Tregs). This is a subset of mostly CD4+ T 
cells which have suppressive effects on other cell types. There appear to be two main 
types of Tregs depending on their origin. The natural Tregs mature in the thymus (Ng et 
al., 2001) while the inducible Tregs (Tr1 and Th3) arise from naive T-cells in the 
periphery when stimulated (Chen et al., 1994). CD8+ Tregs also exist and fall into the 
latter group (Steinbrink et al., 1999).  
 
Tregs are often characterised as CD4+CD25hi cells, due to their ability to constitutively 
express high levels of the IL-5Į-chain (CD25) (Sakaguchi et al., 1995). They also 
constitutively express other markers such as cytotoxic T lymphocyte antigen 4 (CTLA-4) 
(Read et al., 2000) and glucocorticoid-induced tumour necrosis factor (TNF) receptor-
related protein (GITR) (McHugh et al., 2002). Several types of Tregs express the 
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transcription factor forkhead box P3 (FoxP3) which is a vital regulator of suppressive 
gene expression and is required for their development (Fontenot et al., 2003). However, 
the Tr1 Treg subset was reported not to express FoxP3 (Roncarolo et al., 2006). It has 
been demonstrated that, together with promoting the generation of Tregs, FoxP3 also 
suppresses the activity of pro-inflammatory cytokine expression and transcription factors 
involved in T-cell activation such as nuclear factor of activated T-cells (NFAT) and 
NF-țB (Bettelli et al., 2005). The inducible Tregs, Tr1 and Th3, are known to secrete 
suppressive cytokines, for example IL-10 (Groux et al., 1997) and transforming growth 
factor beta (TGF-ȕ(Nakamura et al., 2001). 
 
1.3.2. Mechanisms of action. 
The subject of how Tregs work is a complicated matter as new factors and mechanisms 
emerged recently. Firstly, Tregs may act through a contact-dependent mechanism as 
shown by an in vitro study where Tregs were unable to suppress T effector cells when 
separated by a permeable membrane (Takahashi et al., 1998). Recent research has 
investigated how Tregs initiate this type of mechanism. One possibility is that Tregs 
induce apoptosis by depriving T effector cells of an important cytokine, IL-2 (Pandiyan et 
al., 2007). However, some have found that failure to provide IL-2 is not solely sufficient 
to induce apoptosis (Duthoit et al., 2005). Other have suggested that Tregs have high 
expression of granzyme B which is used to kill target cells directly (Cao et al., 2007). 
Tregs may also release adenosine nucleosides which can cause metabolic disruption of 
their target cells (Bopp et al., 2007). 
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Secondly, Tregs have been found to act on T effector cells via interaction with dendritic 
cells through CTLA-4 or lymphocyte activation gene 3 (LAG3). CTLA-4 was found to 
be constitutively expressed on Tregs (Read et al., 2000) and the suppression activity of 
Tregs was reduced in the absence of CTLA-4 (Serra et al., 2003). Alternatively, 
suppression of T effector could be induced via dendritic cells through a 
CLTA4:CD80/CD86-dependent mechanism (Mellor & Munn, 2004). Another suitable 
candidate, LAG3 has been found to be important for maximal Treg function (Huang et 
al., 2004). 
 
Thirdly, Tregs may act on target cells by expressing regulatory effector molecules which 
are IL-10, TGF-ȕ DQG ,/-35. IL-10 produced by Tregs was found to be important in 
suppressing colitis, an Inflammatory Bowel Disease (IBD) (Asseman et al., 1999). 
However, an adoptive transfer of allergen-specific Tregs induced production of IL-10 
after allergen challenge, by CD4+ T effector instead of Tregs themselves (Kearley et al., 
2005).  
 
Studies on the role of TGF-ȕ SURGXFHG E\ 7UHJV DUH UDWher confusing. In vitro, TGF-ȕ
ZDVDEOH WR VXSSUHVV ,)1ȖSURGXFWLRQ E\7KFHOOV (Lin et al., 2005). A study showed 
that TGF-ȕLVQHHGHGIRUWKHH[SDQVLRQRI7UHJVDVZHOODVIRUWKHLUVXSSUHVVLYHDFWLYLW\
in vivo (Huber et al., 2004). However, CD4+CD25+ T-cells could be induced in TGF-ȕ-
deficient mice and these cells still exhibit their suppressive activity in absence of TGF-ȕ
(Mamura et al., 2004). 
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Another inhibitory cytokine produced by Tregs is the recently discovered factor IL-35. 
This has been found to be important for maximal suppressive activity and could suppress 
T-cell proliferation in vitro (Collison et al., 2007). Another in vitro study confirmed this 
and showed that IL-35 could also induce Treg proliferation (Niedbala et al., 2007). The 
latter study also showed that IL-35 could suppress Th17 differentiation and, under certain 
conditions, inhibit or expand IFNȖSURGXFWLRQE\&'&'- T-cells. 
 
1.3.3. Tregs and disease. 
Tregs play a key role in preventing allergy (Jutel et al., 2003), autoimmunity (Cao et al., 
2003), cancer (Sasada et al., 2003) and harmful inflammatory diseases such as IBD 
(Asseman et al., 1999). Some studies report that Tregs downregulate immunity to 
pathogens. Belkaid et al. showed that an endogenous Treg response is responsible for 
controlling the persistence of Leishmania major in the skin after healing in resistant 
C57BL/6 mice (Belkaid et al., 2002). Others have shown that herpes simplex virus 
(HSV) infection induced the immunosuppressive function of Tregs (Suvas et al., 2003). 
Furthermore, filamentous hemagglutinin of Bordetella pertussis could induce formation 
of Tr1 cells at mucosal surface to suppress B. pertussis-induced Th1 response in vivo 
(McGuirk et al., 2002). 
 
Patients with gastrointestinal malignancies tend to have a higher proportion of 
CD4+CD25+ T cells in their peripheral blood (Sasada et al., 2003). This has also been 
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reported by Perrone et al, who found significantly higher levels of Tregs in gastric 
carcinoma tissue than in normal surrounding tissue (Perrone et al., 2008). Furthermore, 
FOXP3+ Tregs were present in significantly higher numbers amongst tumour-infiltrating 
lymphocytes in gastric cancer compared to lymphocytes from normal gastric tissues 
(Mizukami et al., 2008). These indicate that Tregs may impair anti-tumour immunity. 
 
1.3.4. The relationship between Tregs and H. pylori infection. 
Unless treated, H. pylori infection usually persists lifelong despite a vigorous immune 
and inflammatory response. This persistence may be established by inducing the 
suppressive activity of Tregs. H. pylori infected patients have been reported to have a 
high frequencies of Tregs in the gastric mucosa which dampen immune and inflammatory 
responses (Lundgren et al., 2005a). A study from my research group found that H. pylori-
infected gastric tissue contained greatly increased number of Treg cells. A low-level Treg 
response was significantly associated with the presence of peptic ulcer disease which 
indicates that peptic ulcer disease occurs when there is an insufficient Treg response to 
suppress inflammation (Robinson et al., 2008). It has been shown that Tregs can suppress 
H. pylori-induced T cell responses and anti-tumour immunity, which probably 
contributes to persistence of the infection as well as unchecked tumour growth (Enarsson 
et al., 2006).  
 
Goll et al. measured regulatory cytokine gene expression in the H. pylori infected gastric 
mucosa and found high levels of IL-10 expression which also indicates that IL-10-
secreting Tregs play a role in H. pylori infection (Goll et al., 2007). Higher numbers of 
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CTLA-4 positive mononuclear cells and a higher level of TGF-ȕexpression have been 
found in the lamina propria of H. pylori-infected duodenal ulcer patients as compared to 
asymptomatic carriers (Stromberg et al., 2005). These Tregs were demonstrated to have 
suppressive activity on IL-8 production by gastric epithelial cells. 
 
1.4. Interleukin-10. 
1.4.1. Background and function. 
IL-10 is a potent immunoregulatory cytokine and circulates as a homodimer consisting of 
two tightly packed 160-amino-acid proteins (as reviewed by Opal & DePalo, 2000). Its 
gene is located on the human chromosome 1q31-32 and consists of approximately 5.2 
kbp organized in 5 exons (Kim et al., 1992). IL-10 was first described as cytokine 
synthesis inhibiting factor (CSIF) due to its ability to suppress cytokine synthesis in 
certain T cells (Fiorentino et al., 1989). IL-10 shares nucleic acid and amino acid 
sequence homology with an uncharacterized gene in the Epstein-Barr virus genome, 
BCRF1 (viralIL-10) (Moore et al., 1990). IL-10 is a member of a wider IL-10 family of 
cytokines which includes IL-19, IL-20, IL-22, IL-24, IL-26, IL-28 and IL-29 (as 
reviewed by Commins et al., 2008). 
 
IL-10 is produced by many cell types including B cells (Fillatreau et al., 2002), T cells, 
especially Tregs (Lundgren et al., 2005), monocytes and macrophages (Edwards et al., 
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2006) and dendritic cells (McGuirk et al., 2002), but not epithelial cells. A study using 
IL-10-deficient mice showed that Tregs are an important source of IL-10 (Sydora et al., 
2008). The production of IL-10 from immature dendritic cells can promote the 
differentiation of CD4+ T cells into Tr1 Tregs which express IL-10 (Levings et al., 
2005). Initially, only T helper (Th) 2 cells were known to produce IL-10 (Gazzinelli et 
al., 1992) but recently Th1 cells were reported to produce IL-10 (O'Garra & Vieira, 
2007).  
 
IL-10 and IL-10-secreting Tregs are known to be important for preventing disease in the 
gastrointestinal tract. A study reported that IL-10 was strongly expressed by 
intraepithelial lymphocytes in the small intestine and colonic lamina propria lymphocytes 
after multiple T cell receptor stimulations (Kamanaka et al., 2006). Kullberg et al. have 
shown that IL-10 produced by Tr1 cells can suppress Th1-derived IFN-Ȗ expression in a 
mouse model of IBD using H. hepaticus infection (Kullberg et al., 2002). Their work also 
reported that those Tregs subset inhibited H. hepaticus-induced colitis. 
 
Furthermore, IL-10 could also control inflammatory responses towards intestinal antigens 
(Asseman et al., 1999) and epithelial damage in ulcerative colitis (van der Sluis et al., 
2008). In addition, the constitutively-expressed IL-10 by human normal colonic mucosa 
is important in preventing intestinal barrier disruption by strong IFN-ȖUHVSRQVHV(Jarry et 
al., 2008). In mice with colon cancer, the presence of IL-10-secreting Tregs reduced 
cancer progression (Erdman et al., 2003). However, high serum level of IL-10 has been 
associated with poor prognosis of gastric cancer patients (Ikeguchi et al., 2009). 
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1.4.2. Regulatory effects of IL-10. 
The major role of IL-10 is to suppress inflammation and regulate T-cell subsets 
responses. IL-10 can specifically suppress IFN-Ȗ DQG ,/-2 production by Th1 cells 
(Groux et al., 1998), which was the initial reason for it being named CSIF. Th1 cells are 
the major source of IFN-ȖZKLFKis a potent activator of monocytes and inhibitor of Th2 
proliferation (Mamata et al., 2007). By suppressing IFN-Ȗ ,/-10 helps to maintain 
polarized T helper cells in a Th2 phenotype (Ito et al., 1999).  
 
IL-10 can also inhibit IFN-Ȗ SURGXFWLRQ E\ QDWXUDO NLOOHU 1. FHOOV *D]]LQHOOL et al., 
1992) and block NF-ț%DFWLYDWLRQ7KLVWUDQVFULSWLRQ factor controls expression of many 
pro-inflammatory and antiapoptotic genes (Table 2) and is very important in the 
development of acute and chronic inflammatory diseases (Schottelius et al., 1999). 
Through the blockade of NF-ț%Dctivation, IL-10 inhibited IL-1-mediated induction of 
COX-2 protein synthesis (Al-Ashy et al., 2006) and COX-2 protein expression in 
neutrophils (Niiro et al., 1997). Furthermore IL-10 can inhibit monocyte adherence to 
endothelial cells (Mostafa Mtairag et al., 2001). The expression of IL-17, IL-22, and the 
Th17-cell associated transcription factor retinoic acid-UHODWHGRUSKDQUHFHSWRU525ȖWE\
macrophages and T cells were negatively regulated by IL-10 (Gu et al., 2008).  
 
On the other hand, IL-10 exhibits immunostimulatory properties on B cells and 
endothelial cells (MacDonald et al., 1999). IL-10 can influence mast cell function and 
significantly enhances the growth activity of stem cell factor on these cells (as reviewed 
by Lin & Befus, 1997). When IL-10 is combined with IL-3 and IL-4, the number of mast 
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cell colonies is increased and the production of pure mast cells is augmented (Thompson-
Snipes et al., 1991).  
 
 
H. pylori-induced 
host factors 
regulated by NF-
ț%DFWLYDWLRQ 
Role References 
IL-8 Chemotaxis for neutrophils and 
lymphocytes 
(Chu et al., 2003) 
iNOS Enzyme that generates cell-
damaging NO 
(Lim et al., 2001) 
COX-2 The rate limiting enzyme in the 
synthesis of prostaglandins 
(Kim et al., 2001) 
hBD-2 Anti-bacterial peptide (Wada et al., 2001) 
MMP-9 and -7 Matrix metalloproteinases, 
tumour invasiveness 
(Mori et al., 2003; 
Wroblewski et al., 2003) 
IAP and Mcl-1 Anti-apoptotic genes (Chang et al., 2004; Maeda et 
al., 2002) 
IL-12p40, TNF-Į, 
IFN-Ȗ, IL-2, IL-6 
Pro-inflammatory cytokines (Lu et al., 2005; Takeshima et 
al., 2009; Toyoda et al., 2009) 
VEGF, HIF-1Į Angiogenic growth factors (Yeo et al., 2006) 
Bax  Apoptotic gene (Cha et al., 2009) 
PAI-2 Inhibit fibrinolysis ( degradation 
of blood clots) 
(Varro et al., 2004) 
 
Table 2. Some of the host factors regulated by NF-ț%DFWLYDWLRQLQUHVSRQVHWRH. pylori infection. 
 
 56 
1.4.5. IL-10 and therapy. 
1.4.5.1. Administering IL-10. 
IL-10 is an important anti-inflammatory cytokine which is well-known for its suppressive 
effects. These properties of IL-10 made it a suitable candidate therapeutic for some 
diseases. Numerous studies using animal models reported that administering IL-10, either 
by delivering the IL10 gene, injecting recombinant human IL-10 (rhIL-10), or 
administering agents to promote the induction of IL-10, may prevent diseases such as 
liver fibrosis, airway inflammation and renal impairment (Chou et al., 2006; Nakagome 
et al., 2005; Tipping et al., 1997).  
 
Cua et al. used a replication-defective adenovirus as a vector to directly deliver IL-10 to 
the central nervous system in an animal model of multiple sclerosis and found that IL-10 
effectively blocked disease progression (Cua et al., 2001). Multiple injections of plasmid 
DNA vectors encoding IL-10 into the spinal canal of rats relieved neuropathic pain for 
more than forty days (Milligan et al., 2006). In the latter study, the administration of the 
IL-10 protein only resolved the pain for few hours. These studies showed the importance 
of IL-10 being delivered close to targeted sites and the need for it to be in an active state 
to be useful. 
 
In addition, Lee et al. used non-obese-diabetic mice to see the effect of IL10 gene 
delivery to combat type 1 diabetes, with IL-10 plasmid (pSI-IL-10-1)ț% (Lee et al., 
2006). They found that a single injection of the IL10 gene completely prevented disease. 
IL10 gene therapy could also prevent sepsis in mice (Oberholzer et al., 2002) and 
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experimental colitis in rats (Barbara et al., 2000). In the latter study, timing of gene 
delivery was crucial as a beneficial effect was seen only when the IL10 gene was 
delivered prior to induction of colitis. This is also true in another experimental colitis 
study, where adenoviral vector encoding IL-10 was injected prior to trinitrobenzene 
sulphonic acid induced-colitis to successfully cure the disease (Lindsay et al., 2002). 
 
The role of IL-10 as anti-inflammatory substance has also attracted many therapeutic 
studies for skin diseases. In a mouse model for allergic contact dermatitis (an 
inflammatory skin disorder) animals had less inflammatory cell infiltration and lower 
oedema at the dermis when injected with IL-10 (Kondo et al., 1994). IL-10 was found to 
work by suppressing IFN-Ȗ SURGXFWLRQ, thus further supporting its role as an 
inflammatory inhibitor. Furthermore, IL-10 helped to decrease disease severity in mice 
with Pemphigus vulgaris, an autoimmune bullous skin disease (Toto et al., 2000). 
  
 
IL-10 has also been used as adjuvant in  a mouse model study of an anti-cancer vaccine 
(Kaufman et al., 1999). Mice with induced lung cancer were vaccinated with 
recombinant vaccinia virus followed by injections of IL-10. Although the results were 
promising; with decreasing rates of tumour metastases and low viral titres, its application 
for use in humans would need more validation. In another cancer study, IL-10 was also 
found to significantly inhibit tumour growth and eliminate metastasis in mice with 
melanoma (Huang et al., 1999). 
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In addition, the importance of IL-10 in suppressing inflammation has been demonstrated 
in IL-10-/- PLFH ZKLFK UHVSRQGHG ZLWK KLJK H[SUHVVLRQ RI 71)Į DQG H[FHVVLYH
inflammation upon infection with Mycobacterium tuberculosis (Higgins et al., 2009). A 
similar effect was also shown when neutralising IL-10 antibodies were administered to 
Streptococcus-infected mice (Puliti et al., 2002). In the latter study, a reduction in 
pathology as well as in the expression of inflammatory cytokines was also seen when 
IL-10 was administered.   
 
In contrast to the animal studies, IL-10 therapy has shown a variety of outcomes in 
humans. rIL-JLYHQVXEFXWDQHRXVO\WRSDWLHQWVZLWK&URKQ¶VGLVHDVHKDGOLWWOHHIILFDF\
in treating the disease (Tilg et al., 2002). This could be due to inappropriate timing or 
localization of the rIL-10 (as reviewed by O'Garra et al., 2008). Others have 
demonstrated a significant effect of subcutaneous rIL-10 application to individuals with 
psoriasis (Asadullah et al., 2001), where IL-10 acted to decrease IFN-Ȗ DQG 71)-Į
(Reich et al., 2001). Friedrich et al. reported that after remission of psoriasis, the use of 
long-term subcutaneous IL-10 at a low dose is safe and could prevent the condition from 
recurring (Friedrich et al., 2002). The safe-application of rIL-10 was shown in other 
studies, which also found no side effects from injecting a single large dose of IL-10 to 
healthy volunteers (Fuchs et al., 1996). In the treatment of asthma, agents have been 
administered (e.g. glucocorticoids) which increase IL-10 production. Such treatments 
have been correlated with significant increases in FOXP3 mRNA expression and 
therefore an increased Treg response in asthmatic patients (Karagiannidis et al., 2004).  
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However, IL-10 can also promote pro-inflammatory activity making it a risky choice as a 
therapeutic agent. Administration of rIL-10 to healthy volunteers, either prior to or after 
LPS infection, enhanced IFNȖSURGXFWLRQDQG1.FHOODFWLYLW\(Lauw et al., 2000). These 
data showed that IL-10 administration to individuals with a deficiency in their 
inflammatory response could initiate unwanted pro-inflammatory outcomes. Some mouse 
model studies also demonstrated IL-10 as an agent that worsens disease. IL-10-transgenic 
mice, which over expressed IL-10, had increased tissue inflammation, mucus metaplasia 
and airway fibrosis (Lee et al., 2002). Furthermore, inoculation with Streptococcus 
pneumoniae plus rIL-10 shortened the life expectancy of mice (van der Poll et al., 1996).  
 
1.4.5.2. Neutralising IL-10. 
Several animal studies have shown that blocking IL-10 activity also has a therapeutic 
benefit. Neutralising IL-10 activity either by administering anti-IL-10R monoclonal 
antibody (mAb) or using IL10 gene deletion has effectively been used in combating 
bacterial and viral infection. For example, Brooks et al. demonstrated that the viral load 
after infection with lymphocytic choriomeningitis virus (LCMV) persisted in the 
presence of IL-10 (Brooks et al., 2006). When anti-IL-10R mAb was administered, the 
viral density decreased and the infection was eliminated. This work was supported by 
another study which cleared LCMV infection without causing pathology (Ejrnaes et al., 
2006). In addition, blocking IL-10 activity enhanced the effectiveness of Hepatitis C 
antiviral treatment (Rigopoulou et al., 2005). 
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Blockade of IL-10R has also been used in treating mice infected with Mycobacterium 
tuberculosis (Beamer et al., 2008). In this study, administering anti-IL-10R1 mAb to the 
infected mice, controlled bacterial growth and increased mouse survival rates. Another 
study on Mycobacterium infection also demonstrated the effectiveness of administering 
anti-IL10R mAb to eliminate infection (Silva et al., 2001). This study not only showed 
that blocking IL-10R improves the effectiveness of chemotherapy when the infection is 
latent or chronic, but that the anti-IL-10R mAb is also useful as an adjuvant in 
vaccination against M. avium.  
 
The use of anti-IL-10R mAb as an adjuvant has also proved valuable in some animal 
studies of Leishmania major infection. Vaccination with killed L. major (Okwor et al., 
2009), its DNA (Roberts et al., 2005) or plasmid containing some genes of this parasite 
(Stober et al., 2005) together with anti-IL-10R mAb prior to challenge reduced parasite 
proliferation effectively. In addition, anti-IL-10 treatment itself has proved to be a 
beneficial therapy in Leishmaniasis, at least in animal studies. In the absence of IL-10 or 
with the blockade of IL-10R, rapidly decreased parasite loads of L. major (Kane & 
Mosser, 2001) and Leishmania donovani (Murray et al., 2002) were seen in infected 
mice.  
 
Neutralising IL-10 therapeutic studies have also been tested in oncology. When CpG 
immunostimulatory oligonucleotides and anti-IL-10R mAb were administered 
simultaneously in mouse tumour models, the anti-tumour immune response was 
enhanced compared to administering CpG alone (Vicari et al., 2002). Furthermore, 
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priming for Th1 responses with soluble ovalbumin preparation containing LPS, was 
found successful with the use of anti-IL-10R mAb as adjuvant (Castro et al., 2000). This 
study may be helpful in designing vaccines for immunotherapy. 
 
The therapeutic strategy of silencing the IL10 gene has been applied to skew the immune 
response against tumours or pathogens. Dendritic cells (DCs) transfected with small 
interfering RNA (siRNA) that is specific for the IL10 gene will produce high levels of IL-
12 (Liu et al., 2004) DQG KHOS &' 7 FHOOV WR LQFUHDVH ,)1Ȗ DQG GHFUHDVH ,/-4 
production (Singh et al., 2008). These also promote antiviral activity in cytotoxic T cells. 
However, the increased production of pro-inflammatory cytokines due to the inactivation 
of IL10 gene in T-cells, resulted in severe pathology after Toxoplasma gondii infection 
(Roers et al., 2004). In a human melanoma in vitro study, silencing the IL10 gene in DCs 
increased IL-12 production and improved the cytotoxic T cells response (Chhabra et al., 
2008). 
 
1.4.3. IL-10 receptor and signaling. 
Interleukin-10 bears close topological resemblance to IFN-ȖDQGWKHLUUHFHSWRUFRPSOH[HV
also belong to the same cytokine receptor family (Ding et al., 2001). The IL-10 receptor 
(IL-10R) LV PDGH RI DW OHDVW WZR VXEXQLWV WKH Į-chain (IL-5 DQG WKH ȕ FKDin (IL-
10R2) (as reviewed by Moore et al.7KHĮ-chain, which is a 110-kDa polypeptide, 
has the dominant role in mediating high affinity ligand binding and signal transduction 
(Riley et al., 1999). Its gene is located on human chromosome 11 (Liu et al., 1994). It has 
been shown that IL-10 binds to IL-10R1 with high affinity (Figure 6) and induces 
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changes to the conformation of the IL-10-IL-10R1 complex for the IL-10R2 to come into 
contact with (Yoon et al., 2006). The gene for IL-10R2 is in the same cluster as the IFN-
Ȗ5DQGERWKJHQHVDUHORFDWHGRQFKURPRVRPHV(Reboul et al., 1999). 
 
 
 
Figure 6. A schematic model of IL-10 binding to its receptor.  
IL-10 binds to IL-10R1 with high affinity, followed by low affinity interactions between IL-10R2 and the 
IL-10-IL-10R1 complex (Taken from Yoon et al., 2006). 
 
 
The expression of IL-10R on different types of human cells is a particularly understudied 
area. Most is known about IL-10R on leukocytes but there is very little published on 
other cell types. This is important as we need to understand which cells are capable of 
responding to IL-10 thus modulating their inflammatory responses.  
 
Immune cells are important during inflammation and well known for their high IL-10R 
expression so that they can switch this response off when needed to prevent tissue 
damage. NK cells constitutively express cell surface IL-10R at low density (Carson et al., 
1995). Neutrophils and macrophages were found to express the receptor at cell surface 
but internalised the receptor when stimulated (Du et al., 2006; Elbim et al., 2001). 
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Monocytes express IL-10R at low levels but expression was increased in association with 
diseases such as arthritis (Takasugi et al., 2006). Dendritic cells (MacDonald et al., 
1999), B-cells and T-cells (CD4+ and CD8+) were also reported to express IL-10R (Lai 
et al., 1996). In a study on leukocyte subpopulations of asthmatic patients, monocytes 
and CD4+CD25hi T-cells were found to express the highest level of IL-10R while 
expression of the receptor on CD8+ T-cells, NK cells and neutrophils was low 
(Moniuszko et al., 2009). These indicate that different type of leukocytes may express 
IL-10R differently compared to each other in disease states. 
 
Some non-leukocytes also express the receptor for IL-10 especially cells throughout the 
gastrointestinal tract which are frequently in contact with harmful pathogens. A study on 
Prevotella intermedia, a pathogen in periodontal disease, has confirmed that the 
expression of IL-10R in cultured human dental pulp fibroblasts is induced by the 
presence of bacterial LPS (Tokuda et al., 2003). Evidence from experiments with the 
murine small and large intestine has shown that IL-10 binds to a specific receptor which 
is constitutively expressed on intestinal epithelial cells (Denning et al., 2000). This was 
also shown in vitro, whereby the receptors were found to be constitutively expressed on 
Mode-K cells (a murine intestinal cell line) (Al-Ashy et al., 2006).  
 
The best characterized IL-10 signalling pathway is the Jak/Stat system (as reviewed by 
Moore et al., 2001). The Jak/Stat family consist of four Janus Tyrosine Kinases (Jak1, 
Jak2, Jak3 and Tyk2) and seven latent cytosolic transcription factors (Stat1-Stat6) 
(Weber-Nordt et al., 1996). When the receptors for IL-10 interact with their ligand, 
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members of the Jak family will be phosphorylated and eventually the Jak/Stat pathway 
will be activated (Ding et al., 2001). Specifically, IL-10 affects the activation of Jak1 
(associated with IL-10 receptRUĮFKDLQDQG7\NDVVRFLDWHGZLWKWKH,/-UHFHSWRUȕ
(Riley et al., 1999). In monocytes and T cells, IL-10 stimulates tyrosine phosphorylation 
of Tyk2 and Jak1 together with the activation of STAT1 and STAT3 (as reviewed by 
Finbloom & Winestock, 1995). The binding of IL-10 to its receptor also activates STAT5 
in a murine B-cell line (Wehinger et al., 1996). To date, there is no published data on the 
expression of IL-10R by gastric epithelial cells. 
 
1.4.4. IL-10 super family and sharing of IL-10 receptor 
subunits. 
IL-19, IL-22, IL-24, IL-26, IL-28 and IL-29 are also members of the IL-10 family (as 
reviewed by Commins et al., 2008). These cytokines have approximately 20% amino 
acid sequence identity to IL-10 (as reviewed by Pestka et al., 2004) and have been further 
subdivided into two groups according to the sharing of receptor subunits and gene 
localization. IL-19, IL-20 and IL-24 share the IL-20R2 in their receptor complexes 
(Dumoutier et al., 2001a) and their genes are located close to IL10 gene on chromosome 
1 (Gallagher et al., 2000; Blumberg et al., 2001; Huang et al., 2001). IL-22, IL-26, IL-28 
and IL-29 on the other hand, share the IL-10R2 subunit (Donnelly et al., 2004) and 
except for the later, their genes are located in the same cluster as thHJHQHHQFRGLQJ,)1Ȗ
on chromosome 12 (as reviewed by Pestka et al., 2004). IL-28 and IL-29 are the most 
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recent addition to this family and their genes are located on chromosome 19 (as reviewed 
by Uze & Monneron, 2007). 
 
Unlike IL-10, IL-19 is a monomer (Chang et al., 2003) produced by monocytes and has a 
direct effect on immune cells (Gallagher et al., 2000). Another member of this family, 
IL-20, is also expressed by monocytes (Wolk et al., 2002) and has been associated with 
skin disease. Overexpression of this cytokine leads to psoriasis (Blumberg et al., 2001). 
The melanoma differentiation-associated gene-7 (mda-7) or IL-24, discovered by Jiang et 
al. (1995) has been shown to induce apoptosis in some cancer cells (Saeki et al., 2000). 
This cytokine has also been found to have suppressive effects on the inflamed intestinal 
mucosa in IBD (Andoh et al., 2009). Although IL-19, IL-20 and IL-24 share components 
of their receptor complexes among them, it has been noted that IL-19 and IL-24 are 
growth inhibitory but not IL-20 (Parrish-Novak et al., 2002). 
 
IL-10-related T cell-derived inducible factor (IL-TIF) or IL-22 was discovered in 2000 
and has been intensively studied (Dumoutier et al., 2000a). It is produced by activated T 
cells and NK cells (Wolk et al., 2002). IL-22 has the opposite function from IL-10, 
including pro-inflammatory activity on hepatocytes (Dumoutier et al., 2000b). 
 
AK155 or IL-26 is expressed mainly by T cells and NK cells (Wolk et al., 2002) and 
targets epithelial cells, colon carcinoma cells and keratinocytes (Hor et al., 2004). IL-26 
was initially isolated from herpesvirus saimiri-transformed T cells and formed a 
homodimer, similar to IL-10 (Knappe et al., 2000). High expression of IL-26 has been 
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correlated with increased IL-8 expression which is opposite to the activity of IL-10 
(Dambacher et al., 2008).  
 
IL-28/29 or IFN-Ȝs are type III IFNs which were discovered in 2003 (Kotenko et al., 
2003) and showed anti-tumour activity against B16 melanoma (Lasfar et al., 2006). They 
also have antiviral activity against encephalomyocarditis virus (EMCV) and herpes 
simplex virus type-2 (HSV-2) (Ank et al., 2006).  
 
All IL-10 family members utilise heterodimeric receptor complexes which are composed 
of a type 1 receptor chain (R1) and a type 2 receptor chain (R2) to exert their biological 
effects (as reviewed by Wolk & Sabat, 2006). IL-10 and its receptor have been described 
previously (section 1.4.3). Several IL-10 family cytokines utilise an IL-10R subunit in 
their receptor complexes.  
 
The IL-10R2 subunit is shared with the receptor complexes of IL-10, IL-22, IL-26 and 
IL-28/29 (Figure 7) (Donnelly et al., 2004). Some researchers found that IL-22 binds 
directly to IL-10R2 (Xie et al., 2000) but others have found that it binds to both IL-22R1 
and IL-10R2 subunits (Kotenko et al., 2001). It has a natural antagonist, called IL-22 
binding protein (IL-22BP) which, when bound, inhibits its activity in hepatocytes and 
intestinal epithelial cells (Dumoutier et al., 2001b). The binding of IL-22 to its receptor 
complex also activates STAT1/3, similar to IL-10 and most other IL-10 family cytokines 
(Brand et al., 2006). 
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The IL-26 receptor complex consists of IL-20R1 and IL-10R2 (Hor et al., 2004).  These 
receptor subunits have been found to be expressed by intestinal epithelial cell lines 
(Dambacher et al., 2008). The IL-28/29 receptor complex consists of IL-10R2 and IL-
28RA (Sheppard et al., 2003). 
 
 
 
 
 
 
 
 
 
 
Figure 7. The IL-10R2 chain is shared amongst several IL-10 superfamily cytokine receptor 
complexes.  
The binding of ligands (IL-10, IL-22, IL-26 and IFN-Ȝ,/-28/IL-29)) to their specific ligand binding chain, 
the R1, formed intermediate complexes with the required conformation for the binding of IL-10R2. These 
will then activate JAK and Tyk2 followed by activation of specific STATs. STAT3 is the major 
transcription factor activated by IL-10, IL-22 and IL-26. IFN-Ȝ, however, activates both STAT1 and 
STAT2. These two STATs can combine with IRF-9, another cytosolic protein to form the ISGF3 
transcription factor complex (Taken from Donnelly et al., 2004). 
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1.4.5. IL-10 responses in H. pylori infection. 
1.4.5.1. IL-10 gene polymorphisms. 
Studies on IL-10 gene polymorphisms and disease have been conflicting due to this 
cytokine having both immunosuppressive (potentially cancer promoting) and anti-
angiogenic (potentially cancer inhibiting) properties (as reviewed by Howell & Rose-
Zerilli, 2006). Most of the research has been done on SNPs of the IL-10 promoter region 
which includes position -1082(G/A), -819(C/T) and -592(C/A). Carriers of the IL-10-
1082G/-819C/-592C alleles (GCC haplotype) had higher mucosal IL-10 mRNA levels 
than ATA haplotype carriers (Rad et al., 2004). Furthermore, the ATA/ATA genotype 
has been confirmed to have an association with low IL-10 production (Crawley et al., 
1999). 
 
Polymorphisms that resulted in reduced expression levels of IL-10 have been reported to 
be associated with a higher risk of gastric cancer (El-Omar et al., 2003). Subjects with the 
IL-10-1082AA genotype were at a two-fold higher risk of gastric cancer compared to 
those with an IL-10-1082GG genotype. Furthermore, Kato et al. found a 60% increase in 
the risk of intestinal metaplasia and dysplasia subsequent to H. pylori infection, among 
the carriers of the IL-10-1082 low activity allele (Kato et al., 2006). The subjects for that 
study were known to have extremely high H. pylori infection rates. Another study done in 
an Italian population also showed a higher risk for non-cardia gastric cancer and 
intestinal metaplasia with individuals having IL-10-819TT genotype (Zambon et al., 
2005). This was also true in another case-control study where subjects with T allele at 
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position -819 of the IL-10 promoter region were more at risk of gastritis (46.5%) 
compared to controls (35.7%) (Achyut et al., 2008).  
 
In contrast, others have reported that polymorphisms resulting in increased IL-10 
expression are associated with the increased risk of H. pylori-mediated diseases. For 
example, two studies in a Chinese population have shown that a high IL-10 producer 
genotype was significantly associated with gastric cancer (Lu et al., 2005b; Wu et al., 
2003). Sicinschi et al. (2006) also reported that subjects having the IL-10-592CC 
genotype were associated with more than double of the risk of the intestinal-type gastric 
cancer, and the risk was higher in subjects infected with CagA positive H. pylori. 
Furthermore, in a Japanese population, the presence of an ATA/GCC haplotype of IL-10-
1082/-819/-592 polymorphisms significantly increased the risk of gastric cancer 
development compared to ATA/ATA haplotype (Sugimoto et al., 2007).  
 
1.4.5.2. IL-10 and H. pylori-mediated diseases. 
H. pylori infections were found to be associated with elevated IL-10 expression in the 
human gastric mucosa. Goll et al. reported that the samples from H. pylori-positive 
patients showed an increased of 6.7 fold in IL-10 production compared to the samples 
from H. pylori-negative patients (Goll et al., 2007). A study in a German population has 
confirmed that colonization by more virulent cagA+, vacAs1+ and babA2+ H. pylori 
strains were associated with high level mucosal IL-10 production (Rad et al., 2004). 
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Similar findings also supported that infection with a CagA+ strain is associated with an 
increase in IL-10 mRNA expression (Hida et al., 1999; Robinson et al., 2008).  
 
Studies of H. pylori infections using mouse models have shown a relationship between 
the IL-10 response, intensity of gastric mucosal inflammation and bacterial load (as 
reviewed by Algood & Cover, 2006). Research with IL-10-/- mice has shown that, after 6 
weeks of inoculation, colonization of the gastric mucosa by H. pylori was significantly 
decreased and this reduction was accompanied with enhanced gastric inflammation and 
elevated levels of specific IgA and IgG (Chen et al., 2001). Another similar but longer 
study showed complete eradication of H. pylori and more severe inflammation in IL-10-/- 
mice (Matsumoto et al., 2005).  
 
In addition, a high level of IL-10 was also associated with increased numbers of Tregs in 
the gastric mucosa of H. pylori-infected patients (Lundgren et al., 2003).  This was also 
supported by the study of Lundin et al. which reported high amounts of IL-10 
productions from both peripheral blood and gastric mucosa of H. pylori-infected gastric 
cancer patients (Lundin et al., 2007). In the later study, the IL-10 production from blood 
T cells of H. pylori-infected asymptomatic subject was low.  
 
Furthermore, the presence of high levels of IL-10 produced by Tregs was also linked to 
reduced pathology as found in a study (Lee et al., 2007), using recombination-activating 
gene 2-deficient (Rag2-/-) mice, which are unable to produce T-cells (Vieira et al., 2004). 
Previous studies in our laboratory have shown that gastric biopsy samples with the 
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highest H. pylori densities (graded 3 on a scale of 0-3) contained 6-fold higher levels of 
IL10 mRNA than samples with a grade of 1 (Robinson et al., 2008). When Harris et al. 
evaluated gastric histopathology and Treg cell responses in H. pylori-infected children 
and adults; they found that the level of IL-10 in the antral mucosa of H. pylori-infected 
children was significantly 2 fold higher than the level in infected and uninfected adults 
and 3 fold higher than in uninfected children (Harris et al., 2008). This was correlated 
with infected children having reduced gastritis and higher number of Tregs in the gastric 
mucosa compared to infected adults.  
 
In addition, previous in vitro work in our laboratory also showed a significantly increased 
bacterial density with the addition of 20ng/ml rIL-10 in AGS-H. pylori co-cultures 
(Robinson et al., 2008). This effect was shown via AGS cells because addition of rIL-10 
to H. pylori alone has no direct effect. This indirect effect suggested that AGS cells may 
express the receptor for IL-10 but further experiments were needed to verify this. 
Furthermore, in the same study, H. pylori-induced IL-8 expression was suppressed in 
dose-dependent manner with the addition of rIL-10 in co-cultures of H. pylori with AGS 
cells in vitro. What is more, H. pylori-induced NF-ț% DFWLYDWLRQ LPSRUWDQW IRU ,/-8 
expression) was also inhibited in the presence of rIL-10 in the same co-cultures. Another 
pro-inflammatory marker, ICAM1, which expression was elevated in AGS-H. pylori co-
cultures, was significantly reduced by the addition of rIL-10 (Zakaria et al., 2008). These 
data indicate that IL-10 may suppress H. pylori-induced inflammatory responses which 
allow the bacterium to grow to higher densities and the effects were mediated indirectly 
through gastric epithelial cells. 
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1.5. Aims. 
Reports have shown that IL-10 is abundant in the gastric mucosa during H. pylori 
infection (Lundin et al., 2007; Goll et al., 2007). IL -10 responses have also been 
associated with increased bacterial density and reduced pathology. Previous experiments 
showed that addition of rIL-10 to co-cultures of H. pylori and AGS cells resulted in 
reduced IL-8 response (Robinson et al., 2008). Therefore, it was hypothesised that IL-10 
helps to maintain bacterial colonisation and exerts its effects directly on gastric epithelial 
cells. The aims of this study were: 
1. To investigate the expression of IL-10R subunits by gastric epithelial cells, 
2. To characterise the effects of IL-10 on H. pylori-infected gastric epithelial cell 
lines, 
3. To determine how IL-10 influences H. pylori-induced responses. 
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CHAPTER 2: 
MATERIALS AND 
METHODS 
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All reagents were purchased from Sigma-Aldrich unless otherwise stated. 
 
2.1. H. pylori strains and culture conditions. 
H. pylori strains were grown on blood agar base no.2 plates supplemented with 5% (v/v) 
horse blood (Oxoid Ltd.) at 37oC in a 5% CO2 humidified incubator. The strains used 
were Tx30a ±cagPAI-negative strain (Rieder et al., 1997), vacA s2/m2 (Letley et al., 
2003), 60190 ± cagPAI-positive strain (Rieder et al., 1997), vacA s1/m1 (Letley et al., 
2003), 60190 cagA mutant (Bebb et al., 2006), 60190 cagE mutant (Bebb et al., 2003b) 
and 60190 vacA mutant (Bebb et al., 2003a). 
 
2.2. Cell culture. 
2.2.1. AGS cells. 
AGS cells (ECACC) are human gastric epithelial cells originally derived from an 
adenocarcinoma of the stomach of a 54 year-old Caucasian female with no prior anti-
cancer treatment (http://www.ecacc.org.uk). These cells ZHUH JURZQ LQ ) +DP¶V
nutrient mixture medium, supplemented with 10% (vol/vol) heat inactivated foetal calf 
serum (FCS) and 2mM L-glutamine, at 37oC in a 5% CO2 humidified incubator as 
described by Rieder et al., (Rieder et al., 1997). Once fully confluent, cells were washed 
twice with sterile phosphate buffered saline (PBS) (Oxoid Ltd.) and Trypsin-EDTA 
*LEFR VROXWLRQ ZDV XVHG WR UHPRYH FHOOV IURP WKH IODVN ) +DP¶V QXWULHQW PL[WXUH
 75 
medium was added after trypsinization and cells were washed twice before resuspension 
LQDQDSSURSULDWHYROXPHRI )+DP¶VFXOWXUH PHGLXP7KHFHOO VXVSHQVLRQZDV WKHQ
diluted (split ratio 1:12) into new T75 flasks (Nunclon) with fresh medium and incubated 
as before for maintenance, or cells were seeded into multi-well plates and used for an 
experiment.  
 
2.2.2. MKN28. 
This gastric carcinoma cell line was derived from the stomach of a 70 year-old female 
(http://cellbank.nibio.go.jp/celldata/jcrb0253.htm). 7KH FHOOV ZHUH JURZQ LQ 'XOEHFFR¶V
0RGLILHG(DJOH¶VPHGLXP'0(0ZLWKP0/-glutamine and 10% (vol/vol) FCS at 
37oC in a 5% CO2 humidified incubator. Once fully confluent, the cells were split using 
the same methods as the AGS cells for maintenance or were used in an experiment. 
 
2.2.3. MKN45. 
This gastric carcinoma cell line, derived from the stomach of a 62 year-old female 
(http://cellbank.nibio.go.jp/celldata/jcrb0254.htm), was kindly donated by the Cancer 
Studies Unit, University of Nottingham. The cells were grown in RPMI 1640 medium 
with 2mM L-glutamine and 10% (vol/vol) FCS at 37oC in a 5% CO2 humidified 
incubator. The same routine as AGS cells was used when passaging the cells into a new 
flask. After treatment with trypsin, a cell scraper was used to detach cells from the 
surface of the flask. The cells were washed and diluted into new culture flasks. 
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2.2.4. THP-1. 
THP-1 is a non-adherent human monocytic leukaemia cell line which was derived from 
the peripheral blood of a 1 year old male with acute monocytic leukaemia 
(http://www.ecacc.org.uk). The medium used for this cell line was RPMI 1640 medium 
with 2mM L-glutamine and 10% (vol/vol) FCS. For counting, a sample from the cells 
suspension was diluted with trypan blue and applied to a haemocytometer slide. The cells 
were observed and counted under light microscopy. The cells were kept in exponential 
growth by maintaining cultures between 3-5 x 105 cells/ml. Cultures were incubated at 
37oC in a 5% CO2 humidified atmosphere with the flask in standing position.  
 
2.3. Experimental analysis of IL-10R expression 
by gastric epithelial cells. 
2.3.1. Immunofluorescence microscopy. 
Chamber slides (4-well; BD Biosciences) were seeded with AGS cells from a confluent 
T75 flask and were incubated at 37oC in a 5% CO2 humidified incubator until the next 
day. The total volume of medium used was 1.5ml for each chamber. A H. pylori 60190 
strain suspension was prepared at an optical density of 0.05 (wavelength 600nm) (OD600) 
using F12 medium. Medium from each chamber was replaced with either 1ml of bacterial 
VXVSHQVLRQ RU IUHVK ) +DP¶V QXWULHQW PL[WXUH PHGLXP DSSURSULDWHO\ 7KH FHOOV ZHUH
incubated at 37oC in a 5% CO2 humidified incubator.  
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After 24 hours, staining procedures were carried out. Cells were fixed by replacing 
medium with 1ml of methanol per chamber. Cells were washed twice with 1.5ml 
PBS/0.5% bovine serum albumin (BSA). The solution was removed and a primary 
antibody (mouse anti-IL-5Į5	' systems), rabbit anti-H. pylori (Dako) or an isotype 
control (AbD Serotec)) was added. The cells were incubated at room temperature for 1 
hour and then were washed 3 times with PBS/0.5% BSA solution. The secondary 
antibody (anti-mouse-PE or anti-rabbit-FITC) was added and the cells were incubated in 
the dark at room temperature for 1 hour. The cells were washed as before and the 
manifold of the chamber slide was removed. Coverslips were mounted using anti-fade 
mounting medium (Slow fade Gold; Invitrogen) and the edges of the slides were sealed. 
Cells were visualised by fluorescence microscopy. 
 
2.3.2. Flow cytometry. 
2.3.2.1. FACS analysis using antibodies. 
AGS cells from one fully confluent T75 flask were seeded into 6-well plates and 
incubated at 37oC in a 5% CO2 humidified incubator for 24 hours. Once fully confluent, 
the medium from each well was removed and replaced with 3ml of medium alone or 
medium with a suspension of H. pylori 60190 strain at OD600 0.05.  
 
The THP-1 cell line, known to express IL-10R constitutively and at high-level, was used 
as a positive control (Tan et al., 1993). On the day of infection the number of cells per ml 
was counted using a haemocytometer. Cells were then centrifuged at 200xg and 
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resuspended in an appropriate volume of medium. Cells were suspended in FACS tubes 
at 1x 106 cells per ml. The tubes received either medium alone or bacterial suspension at a 
final OD600 of 0.05. 
 
For AGS cultures, after 24 hours of incubation at 37oC in a 5% CO2 humidified 
incubator, supernatants were removed and PBS was added to wash each well. The PBS 
was removed and 3ml of non-enzymatic cell dissociation agent was added to each well to 
detach the cells from the plate. The cells were incubated for 10 to 15 minutes. Using a 
pipette, cells were scraped from the surface and together with the agent, were transferred 
into FACS tubes. The cells from each well were transferred into separate tubes.  
 
Both AGS and THP-1 cells were washed twice with 1ml PBA/2% FCS and placed on ice. 
Primary antibodies (anti-IL-5Į5	'V\VWHPV or an isotype control (AbD Serotec)) 
were added to designated cell pellets and incubated for 1 hour on ice. The cells were 
washed again 3 times with 1ml PBA/2% FCS. 
 
Secondary antibody anti-mouse-PE was added to the cell pellets and cells were incubated 
for 1 hour on ice. The cells were washed again 3 times and 0.5ml of cell fix solution 
(0.5% formaldehyde in PBS) was added to the cell pellets. Fluorescent labelling was 
detected using a coulter EPICS XL-MCL flow cytometer and WinMDI was used for data 
analysis.  
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2.3.2.2. Measurement of IL-10 binding to cultured cell lines. 
This was done using an IL-10 Fluorokine kit (R&D Systems), following the 
PDQXIDFWXUHU¶VLQVWUXFWLRQVFor AGS cultures, after 24 hours of incubation, supernatants 
were removed and cells were washed twice with 5ml/well PBS. Then, 3ml/well of non-
enzymatic cell dissociation agent was added and cells were incubated for 10 to 15 
minutes before being counted. 1x 106 AGS or THP-1 cells were centrifuged at 200xg for 
5 minutes and washed twice with 2ml wash buffer provided with the kit. Cells were then 
resuspended in 250µl sterile PBS. 25µl cells were added to each tube. 10µl of 
biotinylated rhIL-10 was added to test tubes. 10µl of biotinylated soybean trypsin 
inhibitor was added instead for negative control staining.  
 
To ensure specific staining, controls were included where the interaction of biotinylated 
IL-10 with cells was blocked with anti-IL-10 antibody. 1µl of human IgG (1mg/ml) was 
added into a tube containing 25µl of cells incubated for 15 minutes at room temperature 
(tube A). In a second tube (B), 20µl of anti-human IL-10 antibody was mixed with 10µ l 
of biotinylated rhIL-10 and incubated for 15 minutes at room temperature. The contents 
of tube B were added to tube A and then treated as the others from this point. 
 
All tubes were incubated for 60 minutes at 4oC.  10µl of avidin-FITC reagent was added 
to each tube and the cells were further incubated for 30 minutes at 4oC in the dark. Cells 
were washed twice with 2ml wash buffer and centrifuged at 200xg for 5 minutes. 200µl 
wash buffer was used to resuspend cells for final flow cytometric analysis. Nonviable 
cells were excluded by the addition of 10µl/2x105 cells propidium iodide (PI) 
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(Invitrogen). Fluorescent labelling was detected using a Coulter EPICS Altra flow 
cytometer, gating out cells that stained with PI. WinMDI 2.8 software was used for data 
analysis.  
 
2.3.3. Quantitative real-time reverse transcriptase-polymerase 
chain reaction (real-time RT-PCR). 
 
Total RNA was purified from cultured AGS with and without H. pylori infection using an 
51HDV\ 0LQL .LW 4,$*(1 DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V UHFRPPHQGDWLRQV 7KH
mRNA was reverse transcribed using Superscript II reverse transcriptase (Invitrogen) 
with an oligo(G7SULPHUDVSHUWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVVHH$SSHQGL[IRUIXUWKHU
information). Controls, adding RNase-free water instead of reverse transcriptase (-RT), 
were prepared in parallel for each sample. 
 
The real-time PCR reactions were performed on a Rotor-Gene 3000 (Corbett Research, 
Cambridge, UK) using a Dynamo HS SYBR green qPCR kit (GRI, Braintree, UK). 
Amplification was carried out over 40 cycles of 15 seconds at 95oC, 30 seconds at 61oC, 
30 seconds at 72oC and 15 seconds at 80oC. The IL-10RĮ DQG ,/-5ȕ GDWD ZHUH
normalised to GAPDH. The results were analysed using the Pfaffl method (Pfaffl, 2001).  
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Gene  Forward primer Reverse primer 
GAPDH CCACATCGCTCAGACACCAT GGCAACAATATCCACTTTACCAGAGT 
IL-10RA CTCACCAGGCAGTATTTCACGG CTCTGGGGAGGGACGCTG 
IL-10RB TTCCACAGCACCTGAAAGAGTT AGGATTCTGCTTGCCGCTC 
Table 3. Primer sequences for real-time PCR. 6HTXHQFHVDUHVKRZQLQWKH¶-¶RULHQWDWLRQ 
 
2.3.4. SDS-PAGE and Western blotting. 
 
AGS cells were grown to 80-90% confluence in 6-well plate and were infected the next 
day with H. pylori strain 60190 at an MOI of 10. After 24 hours of infection, cells were 
scraped from the triplicate wells and solubilized in 2x sodium dodecyl sulphate (SDS) 
sample buffer (pH 6.8). Proteins were separated on 10% SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) gels and transferred onto nitrocellulose membrane using the 
Mini Protean 3 apparatus (Bio-5DG +HUWIRUGVKLUH 8. DV SHU WKH PDQXIDFWXUHU¶V
instructions. Blots were blocked for 1 hour at room temperature with PBS/0.05% Tween 
20/2% dried skimmed milk powder and probed with primary antibodies overnight at 4oC. 
The primary antibodies used were mouse anti-human IL-10R alpha monoclonal antibody 
(final concentration, 2µg/ml; R&D Systems) and rabbit anti-human IL-10R beta 
polyclonal antibody (final concentration, 1µg/ml; Santa Cruz Biotechnology, Heidenberg, 
Germany). Blots were washed and incubated with anti-rabbit and anti-mouse peroxidise 
FRQMXJDWH DQWLERGLHV GLOXWLRQV XVHG ZHUH DV SHU PDQXIDFWXUHU¶V instructions). Both 
primary and secondary antibodies were diluted in SignalBoost Immunoreaction Enhancer 
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Solution (Calbiochem®, Nottingham, UK). Ingredients for buffers and solutions for these 
protocols are in the Appendix. 
 
Chemiluminescent ECL Western Blotting Detection Reagents (GE Healthcare Ltd, 
Buckinghamshire, UK) and autoradiography films (ECL hyperfilm; GE Healthcare Ltd) 
were used to develop the blots with an exposure time of 10 minutes. Films were 
developed using developer and fixer chemicals (Ilford PQ Universal, Cheshire, UK) 
before being washed well with water and allowed to dry.  
 
StaininJ IRUȕ-actin was subsequently used to control for protein loading. Briefly, blots 
were washed 2 times in PBS-Tween and re-probed with rabbit- anti-KXPDQ ȕ-actin 
antibody using the same protocol as mentioned earlier. 
 
2.4. Bacterial-epithelial cell co-culture 
experiments and quantification of bacterial 
densities. 
2.4.1. Preparation of AGS cells. 
AGS cells from a fully confluent flask were trypsinised, washed and resuspended in 10ml 
) +DP¶V QXWULHQW PL[WXUH PHGLXP 7he cells were seeded in 24-well plates (Costar, 
Dorset, UK) and incubated as before. For use the next day, cells were seeded at full 
confluence. For use after 2 days, cells were seeded at 50% confluence. For the 
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experiment the cells were at 80-90% confluence and 20ng/ml of recombinant human IL-
10 (rIL-10) (AbD Serotec, Kidlington, UK) was added to appropriate wells. The cells 
were incubated at 37oC in a 5% CO2 humidified atmosphere. 
 
2.4.2. Preparation of H. pylori. 
The growth from two blood agar plates which had been inoculated with H. pylori 24 
hours previously was removed using sterile cotton swabs. The bacteria were suspended in 
5ml serum-IUHH ) +DP¶V QXWULHQW PL[WXUH PHGLXP DQG WKH RSWLFDO GHQVLW\ ZDV
measured on a spectrophotometer at a wavelength of 600nm (OD600). A cuvette 
containing 1ml of medium was used as a blank. It was estimated that an OD600 of 0.01 
contained approximately 5x106 H. pylori colony-forming units (CFU) per ml. The 
dilution required for adding bacteria to the culture wells was calculated so that there 
would be a final OD600 of 0.01 in the well with a total volume of 0.5ml.  
 
2.4.3. Viable count assay. 
After 24 hours, 10-fold dilution series were set up from each co-culture well. Sterile PBS 
with 10% saponin was prepared and 50µl of this solution was added to each well. The 
mixtures were mixed well and 20µl aliquots were removed from each well into the top 
row of a 96-multiwell plate (Nunc). 180µl of fresh sterile PBS was added into this 
making a 1/10 (10-1) dilution. 20µl of this dilution was transferred into the next well 
down and 180µl of PBS was added into this second dilution making a 1/100 (10-2) 
dilution. These steps were continued until the final well which made-up a 1/100,000,000 
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(10-8). Tips were changed between wells. One dilution series was prepared for each 
replicate. 
 
Blood agar plates were marked with four quadrants and were labelled with 10-1 to 10-8 
respectively. 4 times 10µl drops of each dilution were placed onto the blood agar with 
designated quadrant. As a control, 4 times 10µl of PBS were pipetted onto one blood agar 
plate to check for contamination. The spots were allowed to sink before the plates were 
turned over and incubated as before. The colonies were counted after 3 to 5 days of 
incubation. Colony forming units per ml were calculated: 
 
CFU/ml= mean count from replicate 10µl spots x 100 x dilution factor 
 
2.5. Pro-inflammatory chemokine IL-8 assay. 
AGS cells were cultured with and without H. pylori 60190 (MOI=10) in a 6-well plate 
and supernatants were collected after 24 hours of infection. IL-8 was assayed using a 
Human IL- &\WR6HW (/,6$ NLW %LRVRXUVH %HOJLXP DV SHU WKH PDQXIDFWXUHU¶V
instructions. The limit of sensitivity of the assay (typically less than 1.26 pg/ml) was 
calculated as shown below: 
 
Limit of sensitivity = (mean + 3 x standard deviation) of 6 replicate 0pg/ml IL-8 
wells. 
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2.6. Statistical analysis. 
All analyses for statistically significant differences were performed with a paired or 
unpaired Student t test. P<0.05 was considered statistically significant. 
 
 
 
 
 
 
 
 86 
 
 
CHAPTER 3: RESULTS 
 
 
 
 
 
 
 
 
 
 87 
3.1. Measurement of IL-10 receptor expression by 
gastric epithelial cells. 
 
It has been reported that IL-10 is abundant in the gastric mucosa during H. pylori 
infection (Goll et al., 2007) but to date, there have been no reports on whether the IL-10 
receptor (IL-10R) is expressed on gastric epithelial cells. Therefore, experiments were 
done to determine whether IL-10 can act on cells of the epithelium through the IL-10R in 
the presence of H. pylori. 
 
3.1.1. Immunofluorescence microscopy. 
These were qualitative experiments carried out to determine the expression of IL-5Į
on AGS cells with or without the presence of H. pylori. Cells were grown in chamber 
slides and were infected with H. pylori 60190 strain (MOI = 143). After 24 hours of 
incubation, AGS cells were fixed with methanol and the staining procedure was done 
using primary and secondary antibodies. The primary antibodies used were mouse-anti-
IL-5ĮUDEELW-anti-H. pylori (as a positive control) and an isotype control (mouse IgG1, 
negative control). The secondary antibodies used were anti-mouse-PE (phycoerythrin 
conjugate) and anti-rabbit-FITC (fluorescein isothiocynate isomer 1 (FITC) conjugate). 
Stained cells were then examined under fluorescence microscopy.  
 
Red fluorescence was detected when AGS cells, with or without H. pylori 60190 strain, 
were stained with anti-IL-5Į DQWLERG\ 7KH VWDLQLQJ ZDV PRVWO\ SXQFWDWH EXW WKHUH
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were also areas of very high-level staining which maybe non-specific (Figure 8a and b). 
This shows it is likely that AGS cells do express the IL-10R. Green fluorescence was 
detected when AGS cells infected with H. pylori were stained with rabbit-anti-H. pylori 
antibody and anti-rabbit-FITC (Figure 8c). No fluorescence was detected when AGS cells 
were stained with only anti-mouse-PE (figure not shown) illustrating that the binding of 
this secondary antibody is specific. For controls, stained AGS cells alone with anti-H. 
pylori and anti-rabbit-FITC antibodies or with an isotype control antibody (figure not 
shown) also showed no fluorescence.  
 
The microscopy data indicated that the gastric epithelial cell line can express the IL-10R 
either constitutively or induced by H. pylori infection. However, this experiment has a 
limitation since it is a qualitative method. It is not known whether the expression was up-
regulated during infection. In further experiments, flow cytometry was therefore used. 
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Figure 8. Stained AGS cells under fluorescence microscopy: 
AGS cells were left uninfected (a) or infected with H. pylori 60190 strain (b and c) and incubated for 24 
hours. Cells were then stained with mouse-anti-IL-5ĮDQWLERG\DDQGEUDEELW-anti-H. pylori antibody 
(c). Anti-mouse-PE (a and b) and anti-rabbit-FITC (c) were used as secondary antibodies. The presence of 
IL-5ĮLVLQGLFDWHGZLWKWKHUHd fluorescence. 
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c) 
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3.1.2. FACS analysis. 
3.1.2.1. Measurement of IL-10R expression using antibodies. 
The microscopy data showed that gastric epithelial cells did express IL-10R, but it was 
difficult to see whether the expression was increased when the cells were infected with H. 
pylori. The FACS analysis was carried out to determine if IL-10R expression is 
influenced by H. pylori infection. This quantitative analysis was performed to give two 
sets of information: the intensity of fluorescence from the staining of cells with anti-IL-
5Į DQWLERG\ VKRZQ E\ WKH SRVLWLRQ RI WKH SHDN RQ WKH KLVWRJUDP SORWV ZKLFK LV
related to the amount of IL-10R expressed, and the proportion of cells expressing IL-10R 
as shown by the percentage of positively stained cells. For these flow cytometry 
experiments, cells were stained with different primary antibodies and anti-mouse-PE as 
the secondary antibody. 
  
The AGS cells, with and without H. pylori infection, were stained with mouse-anti-IL-
5Į SULPDU\ DQWLERG\ DQG ZLWK DQWL-mouse-PE (secondary) antibody. There was no 
increase in the geometric mean fluorescence (position of the peak) but there was an 
increase in the proportion of positively stained cells when H. pylori was added to the 
AGS cells (Figure 9a and b). These have shown that more AGS cells expressed IL-10R 
but the expression level was not up- regulated within those cells already expressing the 
receptor.  
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It could be seen that the percentage of IL-10R+ cells was increased by 1.5 fold when the 
AGS cells were infected with the bacterium (Figure 9a and b). Unstained AGS cells, with 
and without the presence of H. pylori, resulted in only very small proportions of cells 
within the selected range of fluorescence (M1), 0.21% and 0.49% respectively (Figure 9c 
and d).  
 
 
 
 
 
 
 
 
 
Figure 9. IL-10R FACS analysis of AGS cells: 
AGS cells were either left uninfected (a and c) or infected with H. pylori 60190 strain (b and d). Cells were 
then stained with mouse-anti-IL-5ĮDQWLERG\DDQGERUOHIWXQVWDLQHGFDQGG$QWL-mouse-PE was 
used as the secondary antibody. These histogram plots show intensity of fluorescence on the x-axis and 
number of cells (events) on the y-axis. M1 is the marker region which indicates the fluorescence from 
positive staining. Percentage figures indicate the proportion of events within region M1. 
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The experiment was repeated a further two times and the isotype control was included to 
act as the negative control. Again, there was an increase in IL-5Į H[SUHVVLRQ RQ
infected AGS cells compared to uninfected cells (Figure 10). The increment was 1.7 fold, 
similar to the previous experiment. 
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Figure 10. Fluorescence-sorted IL-10R-positive AGS cells: 
Bars represent the proportion of positively stained AGS cells within the selected range of fluorescence 
(M1). The x-axis is the percentage of positively stained cells and the y-axis is the condition of cells during 
staining.  
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In parallel, the THP-1 cell line was included as a positive control because it has been 
previously reported to express IL-10R constitutively and at high-level (Tan et al., 1993). 
The primary antibodies used were again mouse-anti-IL-5Į DQWLERG\ DQG WKH LVRW\SH
control. The same secondary antibody was used. 78.08% of the THP-1 cells expressed 
IL-10R constitutively and this was increased to 94.19% with H. pylori infection (Figure 
11a and b).  
 
In contrast to AGS cells, a shift in the position of the peak was observed when THP-1 
cells were cultured with H. pylori and together with the increase on the percentage of IL-
10R positive cells (Figure 11a and b) indicates that there were more THP-1 cells 
expressing IL-10R and each cell expressed IL-10R at an increased level when infected 
with H. pylori. When the cells were stained with secondary antibody only or with no 
primary antibody, 5.97% and 0.04% of the THP-1 cells emitted the fluorescent signal 
respectively (Figure 11e and f). The experiment was repeated once with consistent 
results. 
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Figure 11. IL-10R FACS analysis of THP-1 cells:  
Cells were either left uninfected (a, c, e and f) or infected with H. pylori 60190 strain (b and d). Cells were 
then stained with mouse-anti-IL-5ĮDQWLERG\DDQGEWKHLVRW\SHFRQWUROFDQGGRUOHIWXQVWDLQHGH
and f). Anti-mouse-PE was used as the secondary antibody (except in f). These histogram plots show 
intensity of fluorescence on the x-axis and number of cells (events) on the y-axis. M1 is the marker region 
which indicates the fluorescence from positive staining. Percentage figures indicate the proportion of 
events within region M1. 
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Although the amount of isotype control used was the same as with AGS cells, the 
percentage of positively-stained THP-1 cells with isotype control was very high (Figure 
12). High level staining with isotype control antibody indicates that the antibody should 
be used at lower concentrations and that perhaps there was non-specific staining. Due to 
this, another assay needs to be carried out to validate these experiments.  
 
 
 
94.19
30.45
78.08
19.52
5.97 0.04
0
20
40
60
80
100
IL
-
10
R
Is
ot
yp
e
IL
-
10
R
Is
ot
yp
e
2n
d 
Ab
on
ly
Un
st
ai
ne
d
Hp No Hp
%
 
po
s
iti
v
e
ly
 
s
ta
in
e
d 
c
e
lls
No H. pyloriH. ylori
 
Figure 12. Fluorescence-sorted IL-10R-positive THP-1 cells: 
Bars represent the proportion of positively stained THP-1 cells within the selected range of fluorescence 
(M1). The x-axis is the percentage of positively stained cells and the y-axis is the condition of cells during 
staining.  
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3.1.2.2. Measurement of IL-10 binding to gastric epithelial cells. 
The results from FACS assay using antibodies were not adequate. In search of other 
reagents and methods, it was apparent that an IL-10 Fluorokine assay (R&D Systems Ltd, 
Abingdon, UK) has been used by many others to investigate IL-10 interactions 
(Fernandez et al., 2004; Ji et al., 2003; Du et al., 2006). This flow cytometry based assay 
detects the binding of fluorescently labelled IL-10 to cells. It was used to determine IL-10 
binding to epithelial cells cultured with and without H. pylori. Briefly, AGS and THP-1 
cells were infected with H. pylori 60190 strain or left uninfected. They were then 
incubated with biotinylated IL-10, followed by avidin-FITC. The kit included a control 
biotinylated protein to ensure that IL-10 binding was specific. An additional control 
involved pre-incubating the IL-10 with blocking antibodies prior to adding it to the cells. 
 
The mean percentage of IL-10-binding cells was very high for the uninfected cells which 
was about 73% (Figure 13). Surprisingly, the binding was decreased when AGS cells 
were infected with H. pylori 60190 (cag+ strain) and Tx30a (cag- strain) to 40% and 
22% respectively (Figure 13). This decrement was statistically significant (p<0.05). 
However, this was the reversed for THP-1 cell line where the percentage of binding was 
increased with infected cells compared to uninfected cells (Figure 14). Also, the 
percentage of IL-10-binding cells was not as high as AGS cells. 
 
The fluorokine assay was repeated four times with consistent results. The results from 
this assay did not agree with FACS assay using antibodies where a higher proportion of 
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cells expressed IL-5Į ,/-10R expression was therefore investigated using the third 
technique, RT-PCR. 
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Figure 13. IL-10 binding by AGS cells.  
Cells were left uninfected or infected with H. pylori 60190 at MOI of 10 and were used in Fluorokine 
assay. Bars represent the mean percentage of binding from 5 separate experiments and error bars display 
the standard deviations. * indicates significant decrease in IL-10 binding compared with cultures in the 
absence of H. pylori (p<0.05). Hp= H. pylori. 
 
 
 
 
 
 
 
 
 
* * 
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Figure 14. IL-10 binding by THP-1 cells.  
Cells were left uninfected or infected with H. pylori 60190 at MOI of 10 and were used in Fluorokine 
assay. Bars represent the mean percentage of IL-10 binding from 5 separate experiments and error bars 
display the standard deviations. Hp= H. pylori. 
 
 
 
 
3.1.3. IL10R mRNA expression by real-time RT-PCR. 
Primers were designed for the human IL10RA and IL10RB genes. The real-time PCR was 
carried out to measure the relative mRNA expression of IL10RA and IL10RB between 
uninfected and infected AGS cells. Total RNA was extracted from uninfected and 
infected AGS cells. mRNA was reverse-transcribed and used in real-time RT-PCR. The 
ratios of gene expression levels were calculated using the Pfaffl equation (Pfaffl, 2001). 
The data were normalised against GAPDH. Results were reproduced in three individual 
experiments, with each parameter tested in four replicates.  
P=0.05 
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From these experiments, it could be seen that the level of mRNA expression for both 
IL10RA and IL10RB were increased when AGS cells infected with H. pylori. But the 
increment for IL10RB mRNA level (25-fold) was far higher than that of IL10RA (2.5-
fold) (Figure 15). To validate this, IL-10R expression at the protein level was quantified 
by western blotting. 
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Figure 15. Upregulation of IL-10R mRNA expression in infected AGS cells:  
Total RNA was extracted and reverse-transcribed from uninfected and infected AGS cells. Each 
experiment consists of 4-analysed samples. Bars represent the mean fold difference in IL-10RA and IL-
10RB mRNA expression levels between uninfected and infected cells. Error bars represent the standard 
deviation of the mean. The results were reproduced in three individual experiments, with each parameter 
replicated four times. Data were normalised against GAPDH expression. 
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3.1.4. Quantifying IL-10R expression by SDS-PAGE and 
western blotting. 
 
To confirm results from real-time RT-PCR, IL-10R expression by AGS cells was 
investigated using western blotting. AGS cells in 6-well plates were infected with H. 
pylori 60190 strain or left uninfected. After 24 hours of incubation, cells were solubilised 
in 2x SDS buffer and electrophoresed on 10% SDS-PAGE gels. Proteins were then 
transferred onto nitrocellulose membrane and probed with anti-IL-5ĮRUDQWL-IL-5ȕ
antibodies. Membranes were re-probed with anti-ȕ DFWLQ DQWLERG\ WR DFW DV D ORDGLQg 
control.  
 
Figure 16 showed the Western blot results where 63 kDa, 37 kDa and 42 kDa are the 
apparent molecular weight of IL-5Į ,/-5ȕ DQG ȕ-actin respectively. From this, it 
can be seen that the expression of IL-5ĮZDVVLPLODUEHWZHHQXQLQIHFWHGDnd infected 
AGS cells (Figure 16 (ai)). Since the IL-5ĮEDQGVZHUHZHDN LWZDVQRWSRVVLEOH WR
see if there was any difference in intensity. 
 
In contrast, the IL-5ȕ H[SUHVVLRQ ZDV LQFUHDVHG LQ LQIHFWHG FHOOV FRPSDUHG WR
uninfected cells (Figure 16 (bi)). This result was similar to the real-time PCR data. There 
were no bands detected in the control lanes which received no primary antibodies. The 
experiment was repeated and gave consistent results. 
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                                         i) 
                                              M  Hp-  Hp+    M  Hp- Hp+                                                                         
                                                  
                                             Anti-IL-5Į   No Primary Ab 
                                          
                                       
 
    ii) 
                                              M  Hp-  Hp+    M  Hp- Hp+ 
                                                       
                                               Anti-ȕactin    No Primary Ab 
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                                         i) 
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      Anti-IL-5ȕ  No Primary Ab 
                                           
                                          
 
 
 ii) 
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       Anti-ȕactin    No Primary Ab 
 
 
Figure 16. Western blot of IL-5ĮDQG,/-5ȕH[SUHVVLRQLQ$*6FHOOV 
AGS cells were grown in 6-well plates and infected with H. pylori 60190 strain (MOI = 10) or left 
uninfected. Proteins from solubilised cells were electrophoresed in 10% SDS-PAGE gels and transfer to 
nitrocellulose membrane. Blots were probed with anti-IL-5Į DQWLERG\ DL DQGDQWL-IL-5ȕ DQWLERG\
(bi). Blots were re-probed with anti-ȕDFWLQDQWLERG\DLLDQGELLWRVHUYHDVDORDGLQJFRQWURO0 PDUNHU
Hp-= uninfected AGS cells and Hp+ = infected AGS cells with H. pylori 60190 strain. 
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3.2. Bacterial-epithelial cell co-culture 
experiments and quantification of bacterial 
densities. 
Previous studies in the lab have shown that 20ng/ml of rIL-10 induced a significantly 
increased bacterial density (p<0.002) and gastric biopsies with the highest H. pylori 
density grading (3 on a scale of 0-3) contained 6-fold higher levels of IL-10 mRNA than 
the samples with a grade of 1 (Robinson et al., 2008). Further co-culture experiments 
were therefore carried out to confirm or refute the previous work and to determine 
whether it is reproducible.  
 
3.2.1. Dose-dependent effect of rIL-10. 
From previous work, an effect was observed with 20ng/ml but as it is difficult to 
determine whether this concentration is physiologically relevant, effects from lower 
concentrations were tested. As a starting point, the effects of rIL-10 at 5ng/ml, 10ng/ml 
and 20ng/ml of rIL-10 were tested in co-cultures of AGS cells and the 60190 H. pylori 
strain. Each culture condition was carried out in 6 replicates. There was a significant 
increase in bacterial densities with 20ng/ml (p=0.0015), 10ng/ml (p=0.0001) and 5ng/ml 
(p=0.001) of rIL-10 (Figure 17). The experiment was repeated once with consistent 
results. Lower concentration of rIL-10 at 2.5ng/ml was also tested in separate experiment 
but there was no significant effect. 
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Figure 17. Effect of rIL-10 concentration on the density of H. pylori 60190 in dose-dependent 
manner:  
Cells were infected with 60190 H. pylori strain at OD600 0.01 and rIL-10 was added at different 
concentration. Bars show the mean of colony forming units per ml from 6 replicates. Error bars represent 
the standard deviation of the mean. * indicates significant increase compared with cultures in the absence 
of IL-10 (p<0.05). 
 
 
 
3.2.2. Determination of whether growth effects of IL-10 were 
direct or indirect. 
This experiment was to determine whether growth effects of IL-10 mediated directly on 
the bacteria or indirectly via the AGS cells. Infected and uninfected AGS cells were 
added with and without 20ng/ml of rIL-10. There was a significant increase in bacterial 
numbers when rIL-10 was added to the infected AGS cells. No significant increase was 
observed on the addition of rIL-10 to the bacterium alone (Figure 18). The experiment 
was repeated once with consistent results. 
 
*    * * 
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Figure 18. Effect of adding 20ng/ml rIL-10 on H. pylori 60190, with and without AGS cells:  
The bacteria were grown alone or with AGS cells and treated with or without 20ng/ml rIL-10. After 24 
hours (T=24hrs), the number of colony-forming units/ml (CFU/ml) in 6 replicates with and without 
20ng/ml was determined (open bars). Closed bars show the number of colony forming units/ml at 0 hours 
(T=0hr). Bars and error bars represent the mean and standard deviation. * indicates a significant increase 
compared with cultures in the absence of IL-10 (p<0.05) and NS denotes a not significant increase 
compared with cultures in the absence of IL-10. 
 
 
3.2.3. Effect of rIL-10 on different strains. 
Since the last two experiments only examined the effects of IL-10 on the 60190 H. pylori 
which is a cagPaI-positive strain, the next experiment was conducted to see if rIL-10 had 
effects on other strain. Therefore, an experiment was carried out to examine the effect of 
rIL-10 on the cagPaI-negative strain Tx30a. The result showed that rIL-10 significantly 
increased the density of H. pylori 60190 strain bacteria (p=0.004) but no such effects 
   NS 
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were observed with the cagPaI-negative H. pylori Tx30a strain (p=0.347) (Figure 19). 
The experiment was repeated once with consistent results. 
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Figure 19. Effect of adding 20ng/ml rIL-10 on the bacterial density of H. pylori 60190 and Tx30a 
strains:  
AGS cells were infected with 60190 or Tx30a H. pylori strains and were treated with 20ng/ml rIL-10 or left 
untreated. After 24 hours, the number of colony-forming units/ml (CFU/ml) in 6 replicates with and 
without 20ng/ml was determined. Bars show the mean and error bars show the standard deviation. * 
indicates a significant increase compared with cultures in the absence of IL-10 (p<0.05) and NS denotes a 
not significant increase compared with cultures in the absence of IL-10. 
 
3.2.4. Determination of whether the effect of rIL-10 depends on 
the cag pathogenicity island. 
The strains Tx30a and 60190 vary in more than just being positive or negative for the 
cagPaI. Therefore an experiment was carried out to compare the 60190 wild type (WT) 
NS 
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with its isogenic cagE mutant strain which cannot express a functional cag type IV 
secretion system. 
 
After 24 hours incubation, there was no significant increase in the density of H. pylori 
60190 WT bacteria when 10ng/ml rIL-10 was added compared to the number of WT 
bacteria with no addition of rIL-10 (Figure 20). There was no obvious difference in 
bacterial density H. pylori 60190 cagE mutant with or without the addition of rIL-10.  
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Figure 20. The effect of 10ng/ml rIL-10 on the density of H. pylori 60190 WT and cagE mutant:  
AGS cells were infected with 60190 WT or its isogenic cagE mutant strains at OD600 0.01 and were treated 
with 20ng/ml rIL-10 or left untreated. After 24 hours, the number of colony-forming units/ml (CFU/ml) in 
6 replicates with and without 20ng/ml was determined. Bars show the mean and error bars show the 
standard deviation. NS indicates a not significant increase compared with cultures in the absence of IL-10. 
 
 
NS 
NS 
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3.3. Quantification of IL-8 release. 
Expression of the pro-inflammatory chemokine IL-8 was measured to confirm that 
interaction between AGS cells and H. pylori exists. Supernatants from co-culture of AGS 
cells and H. pylori 60190 strain were collected and IL-8 was assayed after 24 hours. 
Figure 21 showed that the production of IL-8 was much higher in infected AGS cells 
compared to uninfected cells and the difference is statistically significant (p<0.0005). The 
experiment was repeated once with consistent results. 
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Figure 21. Expression of IL-8 by AGS cells:  
Cells were left uninfected or infected with 60190 H. pylori strain at MOI=10. Bars show the mean of IL-8 
concentration from six culture wells. Error bars represent the standard deviation of the mean. * indicates 
significant increase of IL-8 release from infected cells compared with cultures of AGS alone (p<0.0005). 
Hp= H. pylori. 
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DISCUSSION 
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Chronic Helicobacter pylori infection is associated with gastritis (Kuipers et al., 1995), 
and may cause diseases such as peptic ulceration, gastric cancer (Graham et al., 2004) 
and gastric MALT lymphoma (Eidt et al., 1994). Only a minority of infected individuals 
suffer symptomatic disease. This is thought to be due to bacterial, host and environmental 
factors which are known to influence the outcome of an infection (Atherton, 1997). One 
of the important host factors involved in modifying the disease outcome is IL-10, an anti-
inflammatory cytokine that exerts regulatory effects on many cells.  
 
Reports have shown that IL-10 is abundant in the human gastric mucosa during H. pylori 
infection (Lundin et al., 2007; Goll et al., 2007). Furthermore, the IL-10 response has 
been correlated with increased bacterial density and reduced pathology (Robinson et al., 
2008) in H. pylori infection. Therefore, in the light of these findings, more detailed 
information on the role of IL-10 in modulating H. pylori-mediated diseases is now 
required. 
 
The purpose of the current study was to firstly investigate IL-10 receptor expression by 
gastric epithelial cells (which orchestrate the inflammatory response to H. pylori 
infection) and secondly to study the effects of IL-10 on these cells when infected in vitro. 
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4.1. IL-10 receptor expression by gastric epithelial 
cell lines. 
To date, nothing has been reported in the literature concerning the expression of IL-10R 
by gastric epithelial cells. It is very important to understand this as gastric epithelial cells 
are probably the main effector cells in defence against H. pylori and IL-10 is a major 
factor in the host response. The important question to address here is whether gastric 
epithelial cells can bind to IL-10 and respond to it. 
 
Although there is no published data on IL-10R expression by gastric epithelial cells, 
studies have shown that epithelial cells from the murine small and large intestine 
constitutively express the receptor for IL-10 (Denning et al., 2000). This was confirmed 
by another study which performed RT-PCR analysis to detect IL10RA (WKHĮ-chain of the 
IL-10 receptor) mRNA, in a mouse intestinal epithelial cell line (Al-Ashy et al., 2006). 
They also utilised FACS analysis to show that IL-10 was able to bind to these cells. One 
interesting study showed induction of IL-10R expression by human dental pulp cells, in 
the presence of bacterial LPS (Tokuda et al., 2003). For that reason, it was hypothesised 
that the levels of IL-10R expression would also be increased upon H. pylori-infection of 
human gastric epithelial cells.  
 
In this study, experiments using immunofluorescence microscopy, flow cytometry, 
RT-PCR and western blotting were carried out to characterise IL-10R expression by 
gastric epithelial cell lines. 
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4.1.1. Immunofluorescence microscopy. 
AGS cells, a human gastric epithelial cell line, were cultured with or without the cagPaI+ 
H. pylori strain 60190 in chamber slides and assayed for IL-10R expression after 24 
hours. Using an anti-IL-5Į PRQRFORQDO DQWLERG\ Lmmunofluorescence microscopy 
indicated that AGS cells did express IL-10R. Several experiments were performed to 
optimise staining conditions; however, the final results were not completely satisfactory. 
Although the staining was mostly punctuate, the background was high, indicating that 
staining may not be specific. Both uninfected and infected AGS cells in this microscopy 
experiments stained positive for the receptor (Figures 7a and b), but it was not possible to 
discern whether the level of expression was changed in response to H. pylori infection 
using this qualitative method.  
 
As an alternative approach, the human IL-10 Fluorokine kit (R&D Systems), which 
permits detection of labelled IL-10 binding, was used with the microscopy method 
described by Michel et al. for staining tissue sections (Michel et al., 1997). No strong 
signals were obtained, even when using a good anti-fade mounting medium. One major 
difference between the methods was the area of staining. The chamber slides tended to 
cause the reagents to accumulate around the edges and the wells were of larger surface 
area. Scaling up the staining volumes did not make any difference. Given the availability 
of smaller multi-well slides, we would like to repeat these experiments.  
 
Microscopy could provide basic information about IL-10R expression by gastric 
epithelial cells, but it is unlikely to be the best technique for analysing IL-10R. 
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Microscopy is most useful when the molecules of interest are expressed at fairly high 
level. Since IL-10R has been found to be expressed at low level in some cells such as NK 
cells (Carson et al., 1995), the level of IL-10R expression on gastric epithelial cells may 
be similar. In this work, the anti-IL-10R antibody may bind to its target molecules but the 
fluorescent signals may be too low to be visible by eye. A more sensitive and quantitative 
method is needed to determine if IL-10R expression is influenced by H. pylori infection. 
Therefore, flow cytometry was used as quantitative method can detect levels of 
fluorescence not apparent by eye. 
 
4.1.2. FACS analysis. 
The flow cytometry experiments were done in two parts, firstly detecting the IL-5Į
expression using anti-IL-5ĮDQWLERG\ WKHQ PHDVXULQJ WKHH[WHQWRI ,/-10 binding to 
gastric epithelial cell lines. As an additional positive control, the human monocytic THP-
1 cell line was included as these cells are known to express IL-10R (Tan et al., 1993). 
 
4.1.2.1. Measurement of IL-10R expression using antibodies. 
Infected and uninfected AGS cells were stained with anti-IL-5ĮDQWLERG\DQGDQDO\VHG
using a flow cytometer for the level of IL-10R expression. Controls included cells stained 
with an irrelevant antibody (isotype control), cells stained only with the secondary 
antibody, or totally unstained cells. All controls showed very low fluorescent signals 
indicating the staining was specific and this assay might be a reliable technique for 
detecting IL-10R expression by gastric epithelial cells. 
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THP-1 cells were found to express much higher levels of IL-10R compared to AGS cells. 
Monocytic cells respond rapidly to infection or components of infectious organisms. 
They express high levels of toll-like receptors and also play an important role in 
inflammation (Bas et al., 2008). Thus, it is a must for them to exhibit high IL-10R 
expression so that they can turn this response off when needed to prevent tissue damage. 
Unfortunately, with this cell line, the controls used were not satisfactory. The percentage 
of IL-10R-positive cells in the isotype control, for both infected and uninfected cells, 
were very high (Figure 11) which meant that the results from AGS cells were unreliable.  
 
Since the antibody specificity was questionable and the level of staining was low, FACS 
experiments using the human IL-10 Fluorokine assay were carried out. This is widely 
used in investigating responsiveness to IL-10, and far better controls were employed.  
 
4.1.2.2. Measurement of IL-10 binding by gastric epithelial cell lines.  
Due to unsatisfactory results from previous IL-10R antibody and flow cytometry 
experiments, this work was extended using a human IL-10 Fluorokine assay. Instead of 
directly measuring the level of IL-10R expression, this assay provided data on the 
proportion of gastric epithelial cells which bound IL-10.  
 
As expected, IL-10 binding of H. pylori-infected THP-1 cells was higher than the 
uninfected cells (Figure 13). THP-1 cells are monocytic cells which are known to play an 
important role in inflammation and should respond rapidly to infection (Bas et al., 2008). 
These cells have been found to express IL-10R upon stimulation (Takasugi et al., 2006). 
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Unexpectedly, a very high percentage of uninfected AGS cells bound IL-10 (73%). The 
proportion was decreased when AGS cells were infected with H. pylori strains 60190 and 
Tx30a (Figure 12). What is more, the percentage of cells that bound IL-10 was the lowest 
when cells were infected with the H. pylori cagPaI-negative strain Tx30a compared to the 
uninfected cells and those infected with the cagPaI-positive strain 60190 cells. Although 
the differences were not statistically significant, the trend indicates that cagPaI activity 
may have caused the cells to bind more IL-10 and would lead to increased IL-10-
mediated effects on infected gastric epithelial cells. 
 
The result should be reliable as two different specificity controls as provided with the kit 
were assayed simultaneously with the test sample. One control consisted of an irrelevant 
protein which was biotinylated to the same degree as IL-10. The other used anti-IL-10 
antibody to specifically block IL-10 binding to its receptor. 
 
 Two other human gastric epithelial cell lines MKN 28 and MKN 45 were tested for 
IL-10 binding, but only AGS cells provided a consistent result. The trends may be 
peculiar to the AGS cell line only and this is a weakness of the study. Since there is no 
literature on IL-10R or IL-10 binding to normal human gastric epithelial cells, this 
research needs to be done. 
 
Although, these cell lines are designated as gastric epithelial cell lines, they exhibit 
different characteristics. AGS cells have an intestinal epithelial cell morphology  
whereas, MKN45 cells exhibit a gastric cell phenotype (Matsuda et al., 2008). Both 
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originate from tumours, therefore it is not possible for them to exhibit many properties, 
such as expression of genes involved in carcinogenesis, differently between them (Zheng 
et al., 2009). They also have different rates of apoptosis (Yang et al., 2004), levels of 
NF-ț% DFWLYDWLRQ (Li et al., 2005) and defensin expression (Bajaj-Elliott et al., 2002). 
Since these were also originally associated with H. pylori infections, therefore they may 
respond differently during infection. Furthermore, it was reported that, STAT3 activity 
which is activated following IL-10 stimulation, was high in AGS and MKN 45 but low in 
MKN 28 (Yu et al., 2004). Thus, these cells are likely to respond differently to IL-10. 
 
Since IL-10 binding to AGS cells decreased upon H. pylori infection, it was speculated 
that IL-10R may be internalized as previously reported for human neutrophils (Elbim et 
al., 2001) and macrophages (Du et al., 2006). In the latter study, the human IL-10 
Fluorokine assay was used which showed a rapid decrease of IL-10 binding to 
macrophages upon stimulation. Although these reports are on phagocytic cells, other 
cytokine receptors e.g. IL-5ĮKDYHDOVREHHQIRXQGWREHSUHGRPLQDQWO\LQWUDFHOOXODU
molecules in human primary bronchial epithelial cells and fibroblasts (Konstantinidis et 
al., 2008). There have been some reports that H. pylori can be found within gastric 
epithelial cell (Lozniewski et al., 2003; Papadogiannakis et al., 2000). This could mean 
that H. pylori as well as other molecules on gastric epithelial cell surface e.g. IL-10R 
could be internalized simultaneously. The fluorokine assay was adapted to determine if 
the IL-10R could be intracellularly located in the AGS cells. For intracellular staining, 
the cells were fixed with 0.5% formaldehyde prior to permeabilisation and staining. 
Unfortunately this resulted in a dramatic reduction in IL-10 binding to uninfected cells. 
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This is probably due to formalin-induced protein cross-links causing structural changes in 
the IL-10R. Other methods to check for localization of IL-10R should be investigated. 
To support this work and confirm its findings, IL-10R expression was further 
investigated using RT-PCR. 
 
 
4.1.3. Measurement of IL10R mRNA expression by real time 
RT-PCR. 
Real-time PCR was carried out to measure the expression of IL10RA and IL10RB in H. 
pylori-infected AGS cells in comparison to uninfected cells. Cells were cultured with and 
without H. pylori 60190 strain in 6-well plates. Cells were harvested and total RNA was 
extracted from these cells. mRNA was reverse-transcribed and used in real-time 
RT-PCR. Primers for the human IL10RA and IL10RB genes were designed so that they 
cross at intron-exon boundaries. Before using them on test samples, primers were 
validated using commercial human cDNA and products were run on 1.5% agarose gel to 
confirm that they were at the required size. Both IL10RA and IL10RB data were 
normalised against GAPDH expression. Results were reproduced in three individual 
experiments, with each parameter tested in four replicates. 
 
It was shown here that the transcripts for IL10RA and IL10RB were expressed in infected 
AGS cells after 24 hours with H. pylori infection (Figure 14) thus confirming the 
previous data. In contrast to the IL-10 Fluorokine data however, expression of both genes 
was up-regulated upon infection. The increment for the IL10RB was far greater than that 
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of IL10RA. It is possible that the high level up-regulation of IL10RB may be due to it 
being utilised in other cytokine receptor complexes such as IL-22R (Donnelly et al., 
2004). Although IL-22RA and IL-10RA are reportedly not expressed on the same cell 
type (Wolk et al., 2004), however, these authors did not study gastric epithelial cells. A 
few human organs have been found to express IL-22R, including the digestive system 
(Wolk et al., 2004). Epithelial cells are one of the cell types found to express IL-22RA 
(as reviewed by Wolk & Sabat, 2006). The gastric epithelial cells may be expressing both 
types of receptor complexes but further investigations need to be done to confirm this.  
 
A limitation of the data is that a comparative method was used. It was not possible to 
determine the actual expression levels of IL10RA and IL10RB. In order to set up a fully 
quantitative PCR, the IL10RA and IL10RB coding sequences could have been cloned into 
a plasmid to be used as a standard curve. Unfortunately, there was no time for this. In 
addition the real time RT-PCR was only measuring IL-10R expression at the transcript 
level, the amounts of translated protein of both subunits were not known. Since there are 
several steps between transcription and translation which control protein expression, 
RT-PCR may give an inaccurate representation of IL-10R protein. In order to address 
this, western blotting was then used to measure IL-10R protein expression. 
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4.1.4. IL-10R protein expression by SDS-page and western 
blotting. 
AGS cells were cultured with and without H. pylori 60190 strain in 6-well plates. Cells 
were solubilised in SDS buffer and protein were electrophoresed on 10% SDS-PAGE 
gels before being transferred onto nitrocellulose membranes. Anti-IL-5Į RU DQWL-IL-
5ȕDQWLERGLHVZHUHXVHGWRSUREHWKHPHPEUDQHV  
 
Using this analysis, the IL-5ĮEDQGGHQVLW\DSSHDUHGWREHDSSUR[LPDWHO\WKHVDPHIRU
uninfected and infected cells (Figure 15 (ai)). However, it was difficult to measure the 
density of the bands as the signals were not strong enough. Even SignalBoost, which has 
been reported to enhance the signal, was used in this experiment but still did not give any 
difference. This result may indicate that the IL-10R was constitutively expressed by AGS 
cells. This may be so since some cell lines such as SF-MA (a human skin fibroblast cell 
line) and U937 (a human monocyte cell line) also have been reported to constitutively 
express IL-10R, and there was no up-regulation when stimulated with LPS (Tokuda et 
al., 2003).  
 
Interestingly, the IL-5ȕH[SUHVVLRQZDVFOHDUO\EHLQJH[SUHVVHG PRUH LQ WKH LQIHFWHG
cells compared to the uninfected cells (Figure 15 (bi)). This result agrees with data from 
the RT-PCR experiments. As mentioned earlier, the very high increment in IL-5ȕ
expression could be due to it being incorporated into other cytokine receptor complexes 
such as IL-22R (Donnelly et al., 2004). This has yet to be confirmed as there is no 
published report on IL-22R expression by AGS cells or other gastric epithelial cell lines. 
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A study reported that IL-10 and IL-22 has been found simultaneously in both systemic 
and local inflammation but, apart from competition for IL-5ȕWKH\GLGQRW LQIOXHQFH
each other (Wolk et al., 2005). 
 
4.1.5. Summary of the findings for IL-10R expression. 
In summary, immunofluorescence microscopy was not a suitable method to detect IL-
10R expression as there was high level background staining indicating that the staining 
may not be specific (Table 4). The FACS analysis using anti-IL-5Į DQWLERG\ DOVR
failed as the isotype control for the THP-1 cells showed very high fluorescent signals and 
therefore the results obtained with AGS may be unreliable. The human IL-10 Fluorokine 
assay, however, may be the most reliable method to use as the controls utilised in this 
method worked well and the results were reproducible.  
 
The IL-10 Fluorokine assay showed that a very high proportion of uninfected AGS cells 
bound IL-10. This could mean that the AGS gastric epithelial cell line expressed IL-10R 
constitutively. The data from this work surprisingly showed a rapid decrease in cell 
surface binding of IL-10 upon H. pylori infection. It is hypothesised that this may be due 
to the receptor being internalised when the cells were infected, as described in another 
study (Du et al., 2006) but experiments to test this were unsuccessful. In addition to using 
the Fluorokine assay, Du et al. confirmed receptor internalization by showing a decrease 
in cell surface IL-10RB subunit using immunoblotting. Similar experiments should be 
carried out to validate the Fluorokine assay data in this study. 
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With RT-PCR and western blotting experiments, this study showed an increase in protein 
and transcript for the IL-10RB subunit when cells were infected with H. pylori. This is 
may be due to the subunit being shared by other receptor complexes such as IL-22R. 
Although there is no published data on IL-10RA and IL-22RA expression in gastric 
epithelial cells so far, these cells may be the target cells for IL-22 as this cytokine has 
been reported to target epithelial cells.  
 
 
 
Techniques Detection of:- 
IL-10RĮ IL-5ȕ IL-10 binding 
(Fluorokine) 
Monoclonal antibodies 
and 
immunofluorescence 
microscopy 
Questionable 
specificity Not done ʊ 
Fluorescent IL-10 and 
immunofluorescense 
microscopy 
ʊ ʊ Very weak signals 
Monoclonal antibodies 
and flow cytometry 
Questionable 
specificity Not done ʊ 
Fluorescent IL-10 and 
flow cytometry 
ʊ ʊ 
Strong specific 
binding to AGS 
cells. Binding 
decreased upon 
infection with H. 
pylori 
RT-PCR Expression 
increased 2.5-fold 
upon infection 
with H. pylori 
Expression 
increased 25-fold 
upon infection with 
H. pylori 
ʊ 
Western blotting Expression 
similar for 
infected and 
uninfected cells 
Expression 
increased in 
infected cells ʊ 
 
Table 4. Techniques used for detection of IL-10R expression and IL-10 binding to AGS cells. 
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4.2. Bacterial-epithelial cell co-culture 
experiments and effects of IL-10 on bacterial 
densities. 
Previous experiments in this study have confirmed that the gastric epithelial cell line, 
AGS does express IL-10R. Although the proportion of cells binding IL-10 was decreased 
when infected with H. pylori, there is still a clear possibility that IL-10 may exert its 
effects during H. pylori infection. Furthermore, previous studies in the lab have shown 
that human gastric biopsies with the highest H. pylori density grading (3 on a scale of 
0-3) contained 6-fold higher levels of IL10 mRNA than the samples with grade of 1 and 
20 ng/ml rIL-10 induced a significantly increased bacterial density (p<0.002) in H. 
pylori-AGS co-cultures in vitro (Robinson et al., 2008). Therefore, H. pylori-AGS co-
culture experiments need to be done to investigate if IL-10 can exert its properties in vitro 
and also to confirm or refute previous findings. 
 
Using viable counting on H. pylori-AGS co-cultures, this study has shown and confirmed 
that adding rIL-10 promoted the growth of H. pylori in dose-dependent manner. 
Additionally, the effect of IL-10 was found to be mediated through gastric epithelial cells 
since there was no significant effect on bacterial growth when H. pylori was cultured 
alone. It was hypothesised that, in the presence of IL-10, gastric epithelial cells may 
produce less antibacterial effector molecules allowing bacteria to survive, or IL-10 may 
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induce the cells to provide a more favourable environment for H. pylori to grow (for 
example, expressing growth factors or increasing intracellular uptake).  
 
The positive effect of IL-10 on the densities of a cagPaI-positive strain but not a 
cagPaI-negative strain, shown in this co-culture study, proved that the presence of this set 
of genes is important for IL-10 to modulate the outcome of infection. For additional 
evidence on the importance of the cagPaI for IL-10-mediated effects, an experiment 
comparing effects of IL-10 in AGS co-cultures with the H. pylori 60190 wild type strain 
and its isogenic cagE mutant was carried out. The results showed that there was an 
increase in growth of the wild type strain when rIL-10 was added but not the mutant. 
Although this did not reach statistical significance, the trend was similar to the 
experiments using 60190 and Tx30a H. pylori strains. IL-10 may therefore be 
suppressing cagPaI-dependent effects on cells. 
 
It has been reported that the cagPaI-encoded T4SS delivers CagA protein (Fischer et al., 
2001) and peptidoglycan (Viala et al., 2004) into the host epithelial cells and activate 
NOD1. This activation will lead to activation of NF-ț%which induces the expression of 
genes encoding pro-inflammatory cytokines, including IL-8 (Chu et al., 2003) and 
defensins such as hBD-2 (Wada et al., 2001). A recent study reported that H. pylori 
induces a cagPaI-dependent increase in mucosal inflammation which is accompanied by 
expression of an array of antimicrobial peptides such as hBD-2 (Hornsby et al., 2008). 
There are many other antibacterial effectors during H. pylori infection but hBD-2 could 
be used as a starting point. Compared to hBD-1, only the gene encoding hBD-2 has the 
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binding sites for NF-ț% LQ WKH SURPRWHU VHTXHQFH RI K%'-2 (Liu et al., 1997). Since 
rhIL-10 has been found to inhibit NF-ț%DFWLYDWLRQDQG,/-8 expression in H. pylori-AGS 
co-cultures (Robinson et al., 2008), it is tempting to speculate that IL-10 also inhibits 
hBD-2 expression by gastric epithelial cells through suppression of NF-ț%DFWLYDWLon.  
 
IL-10 is also known to act on immune and inflammatory cells such as T cells and 
neutrophils (Groux et al., 1998; Niiro et al., 1997) by decreasing their activity. 
Furthermore, H. pylori-infected IL-10-/- mice suffered from severe inflammation then 
cleared the infection (Matsumoto et al., 2005). IL-10 has also been found to suppress IL-
8 secretion and expression of intracellular adhesion molecule-1 (ICAM-1) in H. pylori-
AGS co-culture assays (Zakaria et al., 2008). All of these showed that IL-10 has the 
potential to suppress of the inflammation and support prolonged colonisation of H. pylori 
in the gastric mucosa.  
 
However, increases in bacterial density may lead to higher production of bacterial toxins 
and oxygen radicals in the gastric mucosa long term. These may then promote oxidative 
damage in the host cells and eventually, the host cells may be at higher risk of cancer 
development. This type of damage is not easily repaired and H. pylori eradication must 
be given before the appearance of pre-malignant pathology to completely avoid gastric 
cancer (Farinati et al., 2004). 
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4.3. IL-8 release by AGS cells. 
Many studies have confirmed that increased levels of IL-8 in the gastric mucosa occur in 
association with H. pylori infection (Kim et al., 2001; Ren et al., 2001). Work from our 
research group reported that there were 17-fold higher IL8 mRNA levels gastric tissue 
from infected patients compared to uninfected patients (p<0.0001) (Robinson et al., 
2008). IL-8 expression is a predominant inflammatory marker which is commonly used 
to show that gastric epithelial cells in culture are capable of initiating changes related to 
acute inflammation (Crowe et al., 1995). IL-8 expression was shown previously to be 
down-regulated upon the addition of rhIL-10 in H. pylori-AGS co-cultures in a dose-
dependant manner (Robinson et al., 2008).  The significant (p<0.0005) production of IL-
8 by infected AGS cells in the current study (Figure 20) showed that the in vitro model in 
this study was working as expected, giving similar results to previous published work 
(Robinson et al., 2008) and thus demonstrating the important role of epithelial cells in the 
inflammatory process.  
 
4.4. Critical analysis of the methods. 
4.4.1. Cell lines. 
In this study, human gastric epithelial cell lines originating from adenocarcinoma tissue 
were used since gastric epithelial cells do not survive for longer than 24 hours after 
extraction from normal tissue and are difficult to obtain. It would also be extremely 
difficult to eliminate immune cells and other cells that are present in the gastric 
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epithelium. This would complicate the results as such cell types have been found to 
express IL-10R (Elbim et al., 2001) and IL-10 (Edwards et al., 2006; Lundgren et al., 
2005). Since cancer cells were used, these may exhibit different properties from normal 
cells. In particular, they may not show the same level of IL-10R expression as the non-
malignant gastric epithelium.  
 
Alternative methods for analysis of normal gastric epithelium may be utilized such as 
immunohistochemistry. Sections from biopsies of H. pylori+ and H. pylori- patients could 
be stained with anti-IL-10R antibody or human IL-10 Fluorokine reagents. However, 
endogenous IL-10 may be present and could interfere with the result.  
 
In addition, epithelial cells could be extracted from tissue sections using laser capture 
microdissection (LCM). LCM is a method of isolating cells of interest from heterogenous 
tissue that has been sectioned, with the aid of a microscope, specialist equipment and 
software (Emmert-Buck et al., 1996). These samples could be assayed for IL-10R 
expression using RT-PCR, as described by others (Makino et al., 2008).  
 
4.4.2. Standardising the number of cells added to the wells or 
tubes. 
The precise number of cells in each well may differ in each experiment and this could 
cause variation in the overall outcome of each experiment. Although care has been taken 
to equally distribute the cells into each well during seeding, pipetting errors and cell 
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clumping may have caused some wells to have a slightly different number of cells. 
Moreover, incubation with H. pylori causes some cells to apoptose and therefore there 
would be a reduction in cells remaining after 24 hours.  
 
These differences will contribute to variation within experiments where replicates give a 
broader range. A bigger effect is then needed to be able to observe a statistically 
significant outcome. Furthermore, unequal distribution of cells will also lead to variation 
between experiments as seen when some assays were not very reproducible for example 
human IL-10 Fluorokine assay using MKN28 and MKN45 cell lines.  
 
4.4.3. IL-10R antibodies. 
 In this study, only one monoclonal antibody was used for the detection of IL-5ĮDQGȕ
subunit. Availability of such reagents for immunofluorescence is limited and the anti-IL-
5ĮP$EXVHGLQWKLVVWXG\ZDVQRWactually recommended for this technique. Many of 
these mAbs are recommended to be used with western blotting or immunoprecipitation 
methods. For western blotting, two more antibodies, anti-IL-5Į &-20) polyclonal 
antibody (Santa Cruz) and anti-IL-10R (CD210) mAb (BD Bioscience) were also used, 
but the results were not any better. Between these two, only anti-CD210 is also 
recommended for immunofluorescence but the manufacturer of this antibody could not 
specify to which subunit of the receptor it will bind. Nothing is known about IL-10R 
expression by gastric epithelial cells. It is therefore important to use mAb specific for the 
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IL-10RĮ VXEXQLW VLQFH WKLV truly represents the IL-10R. The IL-5ȕ VXEXQLW KDV EHHQ
found to be part of other cytokine receptor complexes.  
 
4.4.4. Standardising the number of bacteria added to the wells. 
Although numbers of bacteria were carefully distributed equally, it is impossible to 
eliminate errors in putting the same number of bacteria per well. The optical density 
(OD) was used to estimate the concentration of bacteria for infecting AGS or THP-1 
cells, but this is not an actual method for counting viable bacteria as non-viable bacteria 
also absorb light. Furthermore, multiplicity of infection (MOI) was calculated from OD 
value but the actual MOI in the wells maybe different. In order to standardise the inocula 
as much as possible, growth was scraped from plates inoculated 24 hours previously. 
This should ensure that the proportions of viable and non-viable bacteria were of similar 
levels on each occasion. This was important to minimise variation within and between 
experiments.  
 
4.4.5. Quantitative RT-PCR method. 
This technique was used since the IL-10 receptor is thought to be expressed at only a few 
hundred molecules per cell (Tan et al., 1993), and the mRNA expression may also be at 
low levels. It is a sensitive and accurate method but also has some disadvantages such as 
detecting nonspecific PCR products and primer dimers. Fortunately, our hot start PCR 
technique could minimise primer dimer formation (Kellogg et al., 1994). The presence of 
nonspecific products was distinguished by testing non-reverse transcribed RNA in 
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parallel with the test samples. In addition, the melting points for the specific products 
were also used as guidelines. The PCR products were run on 1.5% agarose gels to 
confirm that the predicted size for the required products was correct. It would be more 
specific if Taqman probes were used instead of the SYBR Green method.  
 
Since this is a comparative method of looking at the mRNA level of IL-10R expression, 
the initial amount was not known. A quantitative RT-PCR method could be utilized but 
time was short and this would have required more work as this involves cloning cDNA 
into a plasmid for use in a standard curve. Furthermore, GAPDH gene expression may 
not be the most appropriate housekeeping gene. It would have been useful if an 
experiment was done to confirm that GAPDH expression levels are unchanged upon 
infection of gastric epithelial cells. 
 
4.4.6. Loading control for western blotting. 
A gel loading control is important when using western blotting or any protein 
PHDVXUHPHQWWHFKQLTXHVȕ-actin, used in this study, may not be a reliable loading control 
for western blot analysis as depicted by another study (Dittmer & Dittmer, 2006), which 
VKRZHGWKDWWKHDQWLERG\VSHFLILFWRȕ-actin was not able to differentiate different levels 
of actin protein. It would be useful, if an experiment is done to check the suitability of 
loading controls used as mentioned by a study (Bauer et al., 2009). Furthermore, some 
have found that using two total protein stains (such as SYPRO Ruby and Amido Black) 
may be an acceptable alternatives to a single-SURWHLQFRQWUROVXFKDVȕ-actin or GAPDH 
(Aldridge et al., 2008).  
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4.5. Conclusions. 
 
Taken together, the data in this study highlight a novel and important finding regarding 
IL-10R expression by gastric epithelial cells. This was convincingly shown by RT-PCR 
and western blotting. The finding was expected as the research group had previously 
shown that addition of rIL-10 reduced the IL-8 response of H. pylori infected AGS cells 
(Robinson et al., 2008). However, work on the effects of H. pylori on IL-10 binding 
capacity of AGS cells and IL-10R expression were conflicting. Data indicated that IL-10 
binding was reduced upon infection, but IL-10R expression was increased. These finding 
have not yet been explained but possibly IL-10R molecules may not all be present at the 
surface, or possibly the IL-10RȕVXEXQLWLVLQFRUSRUDWHGLQWRWKH,/-22 receptor complex 
instead. 
 
Results obtained in the viable counting experiments suggest that rIL-10 promotes the 
growth of H. pylori, especially cagPaI+ strains, and the effect is mediated through gastric 
epithelial cells. The human IL-10 Fluorokine assay also showed that a higher proportion 
of H. pylori-cagPaI+ infected AGS cells bound IL-10 compared to cells infected with a 
cagPaI- strain. These data suggest that the presence of the cagPaI is important for the 
ability of H. pylori to modulate the capacity of AGS cells to bind IL-10 and therefore 
IL-10 could carry out its effects on cells such as suppressing NF-ț%DFWLYDWLRQ7KLV LV
thought to be the mechanism of suppressing IL-8 and hBD-2 which help to promote 
bacterial growth.  
 
 130 
4.6. Future work. 
In the future, the immunofluorescence microscopy experiments should be repeated using 
the IL-10 Fluorokine kit as mentioned in a previous study (Michel et al., 1997), and 
perhaps more sensitive methods such as 125Iodine-labelled IL-10 would be useful 
(Denning et al., 2000). More gastric epithelial cell lines would be tested for their IL-10R 
expression to determine if the findings of this study are not just a phenomenon restricted 
to AGS cells only. The IL-10R expression in the human gastric tissue also needs to be 
examined. Monoclonal antibodies of different sources or from different manufacturers 
which are specific for IL-5Į DQG ,/-5ȕ DV ZHOO DV WKRVH UHFRPPHQGHG IRU WKH
techniques used, should be considered. 
 
Furthermore, rIL-10 addition to co-culture experiments on cag mutants should be 
repeated to confirm that IL-10 mediates its effect through a cagPaI-dependent pathway. 
Other cagPaI-positive and cagPaI-negative wild type strains should also be considered. 
This has already been completed by another member of the research group (Zakaria et al., 
2008) which showed a significant increased of bacterial density when administering 
rIL-10 AGS infected with H. pylori wild-type J99 and 11673 (cagPaI+) strains but not 
J63 and J68 (cagPaI-) strains. 
 
Work on the effects of IL-10 upon growth or survival of H. pylori in epithelial cell co-
cultures should be closely investigated. Western blot analysis could be carried out to 
examine IL-10-mediated inhibition of antibacterial effector expression example for 
defensins, reactive oxygen and nitrogen derivatives. Experiments could also be carried 
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out to test whether IL-10 induces the expression of beneficial factors for growth of H. 
pylori. This could be done by adding culture supernatants from rIL-10-treated and 
untreated AGS cells to H. pylori cultures. The effect of the supernatants on bacterial 
growth could be determined by optical density measurements and viable counting.  
 
The best characterized IL-10 signalling pathway, the Jak/STAT system, will be 
elucidated in details. Microarrays could be used for the expression profiling of gastric 
epithelial cells to determine which genes are differentially expressed in response to H. 
pylori and with or without the exposure to IL-10. The genes of particular interest might 
include cytokines, chemokines, adhesion molecules, antibacterial genes (such as 
defensins and cathelicidins) and other genes thought to be associated with pro-
inflammatory responses. 
 
Finally, experiments would investigate whether the pro-inflammatory genes influenced 
by IL-10 in vitro are also differentially expressed in vivo. Human gastric biopsy 
specimens from infected patients would be tested by real-time qPCR for transcript levels 
of IL-10 and other genes that are differentially express in response to IL-10 for example 
IL-8. In addition, the influence of IL-10 in vivo may be tested directly by administering 
either rIL-10, neutralising anti-IL-10 monoclonal antibodies or a placebo to mice. 
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Reagents. 
Flow cytometry buffers 
 
PBS/0.5% BSA (PBA) 
0.5g Albumin from bovine serum (BSA) 
100ml PBS 
 
PBA/2% FCS 
100ml PBS 
0.1g BSA 
0.5ml 20% azide 
2ml FCS 
 
 
SDS-PAGE and western blotting buffers 
 
Reducing sample buffer 
5ml 0.5M Tris-HCl pH6.8 
0.8g SDS 
0.04g bromophenol blue 
20ml glycerol 
0.5ml 2-mercaptoethanol 
10ml distilled water 
 
0.5M Tris-HCl pH6.8 
90.8g Tris base 
300ml distilled water 
HCl for adjusting pH to 6.8 
 
Blocking solution 
1g skimmed milk powder (Marvel) 
50ml PBS-Tween 
 
PBS-Tween 
1L distilled water 
10 PBS tablets 
0.5ml Tween20 (Polyoxythylenesorbitan monolaurate) 
 
Blotting buffer 
5.8g glycine 
11.6g tris base 
7.4ml 10% SDS 
400ml methanol 
Distilled water to total volume 2L 
 
Resolving gel 
2.5ml 1.5M Tris-HCl pH 8.8 
4.0 distilled water 
0.1ml 10% SDS 
3.4ml acrylamide:bis acrylamide (30%:0.8%) 
50µl 10% ammonium persulphate 
10µl TEMED 
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Stacking gel 
1.25ml 0.5M Tris-HCl pH6.8 
3.0ml distilled water 
50µl 10%SDS 
650µl acrylamide:bis acrylamide (30%:0.8%) 
50µl 10% ammonium persulphate 
5µl TEMED 
 
 
Real-time RT-PCR 
 
cDNA synthesis reagents 
 
Reagents Volume per tube(µl) 
Oligo(dT) primer 0.5 
RNA template (25µg/µl) 4 
dNTP mix (10mM each) 1 
RNAse free water 6.5 
5x first strand buffer 4 
RNAseOut 1 
0.1M DTT 2 
 
Real-time PCR reaction mixture 
Reagents Volume per tube (µl) 
Dynamo HS SYBR Green 10 
Forward primer 2 
Reverse primer 2 
RNAse free water 2 
cDNA template 4 
 
Glossary 
 
 
Intestinal metaplasia ± replacement of gastric epithelial cells with those of intestinal type 
Dysplasia ± abnormality of maturation of cells within a tissue 
Gastric antrum ± the lower part of the stomach  
Lymphoma ± cancer that affects lymphocytes 
Hypochlorhydria ± low level of gastric acid in the stomach 
Atrophic gastritis ± loss of gastric glands 
Oedema ± abnormal accumulation of fluid beneath the skin or cavities of the body 
 
